Cinemark (CNK) 10-Q 4 Nov 22 2022 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2022	Oct. 30, 2022	Oct. 28, 2022
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Entity Registrant Name	Cinemark Holdings, Inc.
Entity Central Index Key	0001385280
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding			120,424,973
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Shell Company	false
Entity File Number	001-33401
Entity Tax Identification Number	20-5490327
Entity Address, Address Line One	3900 Dallas Parkway
Entity Address, City or Town	Plano
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	75093
City Area Code	972
Local Phone Number	665-1000
Entity Incorporation, State or Country Code	DE
Document Quarterly Report	true
Document Transition Report	false
Title of Each Class	Common stock, par value $.001 per share
Trading Symbol(s)	CNK
Name of each exchange on which registered	NYSE
CUSA
Document Information [Line Items]
Entity Registrant Name	Cinemark USA, Inc.
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Shell Company	false
Entity File Number	33-47040
Entity Tax Identification Number	75-2206284
Entity Address, Address Line One	3900 Dallas Parkway
Entity Address, City or Town	Plano
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	75093
City Area Code	972
Local Phone Number	665-1000
Entity Incorporation, State or Country Code	TX
Common Class A [Member] | CUSA
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		1,500,000,000
Common Class B [Member] | CUSA
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		182,648,000,000

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions		Sep. 30, 2022	Dec. 31, 2021
Current assets
Cash and cash equivalents		$ 631.9	$ 707.3
Inventories		19.6	15.5
Accounts receivable		52.4	68.8
Current income tax receivable		45.4	46.6
Prepaid expenses and other		51.6	36.2
Total current assets		800.9	874.4
Theatre properties and equipment, net		1,260	1,382.9
Operating lease right-of-use assets, net		1,144	1,230.8
Other assets
Goodwill	[1]	1,249.2	1,248.8
Intangible assets, net		309.1	310.8
Investments in affiliates		26.3	25.2
Deferred charges and other assets, net		32.6	22.3
Total other assets		1,645.6	1,742.5
Total assets		4,850.5	5,230.6
Current liabilities
Current portion of long-term debt		22	24.3
Current portion of operating lease obligations		217.9	217.1
Current portion of finance lease obligations		14.6	14.6
Current income tax payable		2.4	0
Accounts payable and accrued expenses		371.5	513.1
Total current liabilities		628.4	769.1
Long-term liabilities
Long-term debt, less current portion		2,473.5	2,476.3
Operating lease obligations, less current portion		987.6	1,078.3
Finance lease obligations, less current portion		91.6	102.6
Long-term deferred tax liability		39.5	39.8
Long-term liability for uncertain tax positions		47.3	45.9
NCM screen advertising advances		340.5	346
Other long-term liabilities		36.7	38.1
Total long-term liabilities		4,016.7	4,127
Cinemark Holdings, Inc.'s stockholders' equity:
Common stock value		0.1	0.1
Additional paid-in-capital		1,214.1	1,197.8
Treasury stock		(95.2)	(91.1)
Retained deficit		(561.3)	(389.4)
Accumulated other comprehensive loss		(362.9)	(394.5)
Total Cinemark Holdings, Inc.'s stockholders' equity		194.8	322.9
Noncontrolling interests		10.6	11.6
Total equity		205.4	334.5
Total liabilities and equity		4,850.5	5,230.6
NCM
Other assets
Investment		28.4	135.4
CNK [Member]
Long-term liabilities
Long-term debt, less current portion		2,473.5	2,476.3
Cinemark Holdings, Inc.'s stockholders' equity:
Accumulated other comprehensive loss		(362.9)	(394.5)
CUSA [Member]
Current assets
Cash and cash equivalents		386.6	442.7
Inventories		19.6	15.5
Accounts receivable		52.1	68.8
Current income tax receivable		45.4	46.6
Prepaid expenses and other		51.6	36.2
Accounts receivable from parent		60.5	46.7
Total current assets		615.8	656.5
Theatre properties and equipment, net		1,260	1,382.9
Operating lease right-of-use assets, net		1,144	1,230.8
Other assets
Goodwill		1,249.2	1,248.8
Intangible assets, net		309.1	310.8
Investments in affiliates		26.3	25.2
Deferred charges and other assets, net		32.6	22.3
Total other assets		1,645.6	1,742.5
Total assets		4,665.4	5,012.7
Current liabilities
Current portion of long-term debt		22	24.3
Current portion of operating lease obligations		217.9	217.1
Current portion of finance lease obligations		14.6	14.6
Current income tax payable		2.4	0
Accounts payable and accrued expenses		368.5	504.6
Total current liabilities		625.4	760.6
Long-term liabilities
Long-term debt, less current portion		2,023.4	2,028.7
Operating lease obligations, less current portion		987.6	1,078.3
Finance lease obligations, less current portion		91.6	102.6
Long-term deferred tax liability		58.4	57.8
Long-term liability for uncertain tax positions		47.3	45.9
NCM screen advertising advances		340.5	346
Other long-term liabilities		36.6	37.9
Total long-term liabilities		3,585.4	3,697.2
Cinemark Holdings, Inc.'s stockholders' equity:
Additional paid-in-capital		1,474.5	1,459
Treasury stock		(24.2)	(24.2)
Retained deficit		(687.6)	(544)
Accumulated other comprehensive loss		(368.2)	(397)
Total Cinemark Holdings, Inc.'s stockholders' equity		444	543.3
Noncontrolling interests		10.6	11.6
Total equity		454.6	554.9
Total liabilities and equity		4,665.4	5,012.7
CUSA [Member] | NCM
Other assets
Investment		28.4	135.4
CUSA [Member] | Common Class A [Member]
Cinemark Holdings, Inc.'s stockholders' equity:
Common stock value		0	0
CUSA [Member] | Common Class B [Member]
Cinemark Holdings, Inc.'s stockholders' equity:
Common stock value		$ 49.5	$ 49.5
[1] Balances are presented net of accumulated impairment losses of $ 214.0 for the U.S. operating segment and $ 43.8 for the international operating segment. See discussion of the qualitative impairment analysis performed by the Company as of September 30, 2022 at Note 12.

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	126,080,000	125,100,000
Common stock, shares outstanding	120,430,000	119,750,000
Treasury stock, shares	5,660,000	5,350,000
Accumulated depreciation	$ 2,132.1	$ 1,985.9
CUSA [Member]
Treasury stock, shares	57,245,000,000	57,245,000,000
Accumulated depreciation	$ 2,132.1	$ 1,985.9
Common Class A [Member] | CUSA [Member]
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	10,000,000,000,000	10,000,000,000,000
Common stock, shares issued	1,500,000,000	1,500,000,000
Common stock, shares outstanding	1,500,000,000	1,500,000,000
Common Class B [Member] | CUSA [Member]
Common stock, par value	$ 0	$ 0
Common stock, shares authorized	1,000,000,000,000	1,000,000,000,000
Common stock, shares issued	239,893,000,000	239,893,000,000
Common stock, shares outstanding	182,648,000,000	182,648,000,000

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF LOSS - USD ($) shares in Millions, $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenue
Total revenue		$ 650.4	$ 434.8	$ 1,855	$ 843.8
Cost of operations
Impairment of long-lived and other assets		15.2	7.5	107.5	7.5
Other income (expense)
Equity in income (loss) of affiliates				(7.5)	(22.1)
Net loss		(23.9)	(77.6)	(169.2)	(428.7)
Net loss attributable to Cinemark Holdings, Inc.		$ (24.5)	$ (77.8)	$ (171.9)	$ (428.5)
Weighted average shares outstanding
Basic		118.4	117.3	118.1	117.2
Diluted		118.4	117.3	118.1	117.2
Loss per share attributable to Cinemark Holdings, Inc.'s common stockholders
Basic		$ (0.20)	$ (0.65)	$ (1.43)	$ (3.59)
Diluted		$ (0.20)	$ (0.65)	$ (1.43)	$ (3.59)
NCM
Other income (expense)
Interest expense - NCM				$ (17.5)	$ (17.7)
DCIP
Other income (expense)
Distributions from DCIP	[1]	$ 3.7	$ 6.5	3.7	6.5
Admissions
Revenue
Total revenue		324.6	225.5	942.3	435.1
Concession
Revenue
Total revenue		253.6	164.2	712.6	313.5
Other
Revenue
Total revenue		72.2	45.1	200.1	95.2
CNK
Revenue
Total revenue		650.4	434.8	1,855	843.8
Cost of operations
Film rentals and advertising		180.9	117	531.1	216.8
Concession supplies		46.3	28.2	128.8	54.2
Salaries and wages		97	67.6	277	149.2
Facility lease expense		77.2	68.8	231.2	200.8
Utilities and other		110.4	81.7	303.8	192
General and administrative expense		45.1	38.6	134	111.8
Depreciation and amortization		58.3	67.2	181	202.3
Impairment of long-lived and other assets		15.2	7.5	107.5	7.5
Restructuring costs		0	(0.4)	(0.2)	(1.3)
(Gain) loss on disposal of assets and other		1.2	1.1	(6.4)	7.9
Total cost of operations		631.6	477.3	1,887.8	1,141.2
Operating income (loss)		18.8	(42.5)	(32.8)	(297.4)
Other income (expense)
Interest expense		(38.4)	(38)	(114.6)	(111.6)
Interest income		6.4	0.8	11.1	5.3
Loss on extinguishment of debt		0	0	0	(6.5)
Foreign currency exchange loss		(5.4)	(0.2)	(5.3)	(0.9)
Equity in income (loss) of affiliates		0.2	(7.2)	(7.5)	(22.1)
Total other expense		(39.3)	(44)	(130.1)	(146.9)
Loss before income taxes		(20.5)	(86.5)	(162.9)	(444.3)
Income taxes		3.4	(8.9)	6.3	(15.6)
Net loss		(23.9)	(77.6)	(169.2)	(428.7)
Less: Net income (loss) attributable to noncontrolling interests		0.6	0.2	2.7	(0.2)
Net loss attributable to Cinemark Holdings, Inc.		$ (24.5)	$ (77.8)	$ (171.9)	$ (428.5)
Weighted average shares outstanding
Basic		118.4	117.3	118.1	117.2
Diluted		118.4	117.3	118.1	117.2
Loss per share attributable to Cinemark Holdings, Inc.'s common stockholders
Basic		$ (0.20)	$ (0.65)	$ (1.43)	$ (3.59)
Diluted		$ (0.20)	$ (0.65)	$ (1.43)	$ (3.59)
CNK | NCM
Other income (expense)
Distributions from NCM		$ 0			$ 0.1
Interest expense - NCM		(5.8)	(5.9)	(17.5)	(17.7)
CNK | DCIP
Other income (expense)
Distributions from DCIP		3.7	6.5	3.7	6.5
CNK | Admissions
Revenue
Total revenue		324.6	225.5	942.3	435.1
CNK | Concession
Revenue
Total revenue		253.6	164.2	712.6	313.5
CNK | Other
Revenue
Total revenue		72.2	45.1	200.1	95.2
CUSA
Cost of operations
Film rentals and advertising		180.9	117	531.1	216.8
Concession supplies		46.3	28.2	128.8	54.2
Salaries and wages		97	67.6	277	149.2
Facility lease expense		77.2	68.8	231.2	200.8
Utilities and other		110.4	81.7	303.8	192
General and administrative expense		44.4	37.9	131.8	109.7
Depreciation and amortization		58.3	67.2	181	202.3
Impairment of long-lived and other assets		15.2	7.5	107.5	7.5
Restructuring costs		0	(0.4)	(0.2)	(1.3)
(Gain) loss on disposal of assets and other		1.2	1.1	(6.4)	7.9
Total cost of operations		630.9	476.6	1,885.6	1,139.1
Operating income (loss)		19.5	(41.8)	(30.6)	(295.3)
Other income (expense)
Interest expense		(32.4)	(31.9)	(96.5)	(93.5)
Interest income		5.2	0.9	9.5	5.3
Loss on extinguishment of debt		0	0	0	(6.5)
Foreign currency exchange loss		(5.4)	(0.2)	(5.3)	(0.9)
Equity in income (loss) of affiliates		0.2	(7.2)	(7.5)	(22.1)
Total other expense		(34.5)	(37.8)	(113.6)	(128.8)
Loss before income taxes		(15)	(79.6)	(144.2)	(424.1)
Income taxes		0.4	(7.4)	3.3	(11.3)
Net loss		(14.6)	(72.2)	(140.9)	(412.8)
Less: Net income (loss) attributable to noncontrolling interests		0.6	0.2	2.7	(0.2)
Net loss attributable to Cinemark Holdings, Inc.		(15.2)	(72.4)	(143.6)	(412.6)
CUSA | NCM
Other income (expense)
Distributions from NCM		0	0	0	0.1
Interest expense - NCM		5.8	5.9	17.5	17.7
CUSA | DCIP
Other income (expense)
Distributions from DCIP		$ 3.7	$ 6.5	$ 3.7	$ 6.5
[1] Cash distributions received from DCIP are not treated as a reduction of the investment balance because, as discussed above, the Company's equity investment in DCIP is zero. Reflected as distributions from DCIP on the condensed consolidated statements of loss.

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Net loss	$ (23.9)	$ (77.6)	$ (169.2)	$ (428.7)
Other comprehensive income (loss), net of tax
Foreign currency translation adjustments			(5.9)	(15)
CNK
Net loss	(23.9)	(77.6)	(169.2)	(428.7)
Other comprehensive income (loss), net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes and settlements	11.6	1.4	34.2	7.9
Foreign currency translation adjustments	(4.6)	(13.8)	(5.9)	(15)
Total other comprehensive income (loss), net of tax	7	(12.4)	28.3	(7.1)
Total comprehensive loss, net of tax	(16.9)	(90)	(140.9)	(435.8)
Comprehensive (income) loss attributable to noncontrolling interests	(0.6)	(0.2)	(2.7)	0.2
Comprehensive loss attributable to Cinemark Holdings, Inc.	(17.5)	(90.2)	(143.6)	(435.6)
CUSA
Net loss	(14.6)	(72.2)	(140.9)	(412.8)
Other comprehensive income (loss), net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes and settlements	9.8	1.4	31.4	7.9
Foreign currency translation adjustments	(4.6)	(13.8)	(5.9)	(15)
Total other comprehensive income (loss), net of tax	5.2	(12.4)	25.5	(7.1)
Total comprehensive loss, net of tax	(9.4)	(84.6)	(115.4)	(419.9)
Comprehensive (income) loss attributable to noncontrolling interests	(0.6)	(0.2)	(2.7)	0.2
Comprehensive loss attributable to Cinemark Holdings, Inc.	$ (10)	$ (84.8)	$ (118.1)	$ (419.7)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Millions	Total	Common Stock	Treasury Stock	Additional Paid-In-Capital	Retained earnings (deficit)	Accumulated other comprehensive loss	Total Cinemark Holdings, Inc.'s Stockholders' Equity	Noncontrolling Interests	CNK	CUSA	CUSA Common Stock	CUSA Treasury Stock	CUSA Additional Paid-In-Capital	CUSA Retained earnings (deficit)	CUSA Accumulated other comprehensive loss	CUSA Total Cinemark Holdings, Inc.'s Stockholders' Equity	CUSA Noncontrolling Interests
Balance, beginning of period at Dec. 31, 2020	$ 798.9	$ 0.1	$ (87)	$ 1,245.6	$ 27.9	$ (398.7)	$ 787.9	$ 11		$ 785	$ 49.5	$ (24.2)	$ 1,310.6	$ (163.3)	$ (398.6)	$ 774	$ 11
Impact of adoption of ASU 2020-06, net of tax | ASU 2020-06	(68.2)			(73.6)	5.4		(68.2)
Issuance of share based awards and share based awards compensation expense	4.7			4.7			4.7			4.4			4.4			4.4
Contributions from parent										120			120			120
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes and settlements	5.7					5.7	5.7			5.7					5.7	5.7
Net income (loss)	(208.9)				(208.3)		(208.3)	(0.6)		(203.5)				(202.9)		(202.9)	(0.6)
Foreign currency translation adjustments										(9.5)					(9.5)	(9.5)
Foreign currency translation adjustments	(9.5)					(9.5)	(9.5)
Amortization of accumulated losses for amended swap agreements	1.1					1.1	1.1			1.1					1.1	1.1
Balance, end of period at Mar. 31, 2021	523.8	0.1	(87)	1,176.7	(175)	(401.4)	513.4	10.4		703.2	49.5	(24.2)	1,435	(366.2)	(401.3)	692.8	10.4
Balance, beginning of period at Dec. 31, 2020	798.9	0.1	(87)	1,245.6	27.9	(398.7)	787.9	11		785	49.5	(24.2)	1,310.6	(163.3)	(398.6)	774	11
Contributions from parent										120
Net income (loss)	(428.7)								$ (428.7)	(412.8)
Foreign currency translation adjustments	(15)								(15)	(15)
Balance, end of period at Sep. 30, 2021	314.8	0.1	(87)	1,188.6	(395.2)	(402.5)	304	10.8		504.4	49.5	(24.2)	1,446.5	(575.9)	(402.3)	493.6	10.8
Balance, beginning of period at Mar. 31, 2021	523.8	0.1	(87)	1,176.7	(175)	(401.4)	513.4	10.4		703.2	49.5	(24.2)	1,435	(366.2)	(401.3)	692.8	10.4
Issuance of share based awards and share based awards compensation expense	5.9			5.9			5.9			5.7			5.7			5.7
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes and settlements	0.8					0.8	0.8			0.8					0.8	0.8
Net income (loss)	(142.2)				(142.4)		(142.4)	0.2		(137.1)				(137.3)		(137.3)	0.2
Foreign currency translation adjustments										8.3					8.3	8.3
Foreign currency translation adjustments	8.3					8.3	8.3
Amortization of accumulated losses for amended swap agreements	1.1					1.1	1.1			1.1					1.1	1.1
Balance, end of period at Jun. 30, 2021	397.7	0.1	(87)	1,182.6	(317.4)	(391.2)	387.1	10.6		582	49.5	(24.2)	1,440.7	(503.5)	(391.1)	571.4	10.6
Share based awards compensation expense										5.8			5.8			5.8
Issuance of share based awards and share based awards compensation expense	6			6			6
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes and settlements	1.4					1.4	1.4			1.5					1.5	1.5
Net income (loss)	(77.6)				(77.8)		(77.8)	0.2	(77.6)	(72.2)				(72.4)		(72.4)	0.2
Foreign currency translation adjustments									(13.8)	(13.8)					(13.8)	(13.8)
Foreign currency translation adjustments	(13.8)					(13.8)	(13.8)
Amortization of accumulated losses for amended swap agreements	1.1					1.1	1.1			1.1					1.1	1.1
Balance, end of period at Sep. 30, 2021	314.8	0.1	(87)	1,188.6	(395.2)	(402.5)	304	10.8		504.4	49.5	(24.2)	1,446.5	(575.9)	(402.3)	493.6	10.8
Balance, beginning of period at Dec. 31, 2021	334.5	0.1	(91.1)	1,197.8	(389.4)	(394.5)	322.9	11.6		554.9	49.5	(24.2)	1,459	(544)	(397)	543.3	11.6
Issuance of share based awards and share based awards compensation expense	5.1			5.1			5.1			4.9			4.9			4.9
Stock withholdings related to share based awards that vested during the period	(1.6)		(1.6)				(1.6)
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes and settlements	18.4					18.4	18.4			14.6					14.6	14.6
Net income (loss)	(72.5)				(74)		(74)	1.5		(61)				(62.5)		(62.5)	1.5
Foreign currency translation adjustments										14.4					14.4	14.4
Foreign currency translation adjustments	14.4					14.4	14.4
Amortization of accumulated losses for amended swap agreements	1.1					1.1	1.1			1.1					1.1	1.1
Balance, end of period at Mar. 31, 2022	299.4	0.1	(92.7)	1,202.9	(463.4)	(360.6)	286.3	13.1		528.9	49.5	(24.2)	1,463.9	(606.5)	(366.9)	515.8	13.1
Balance, beginning of period at Dec. 31, 2021	334.5	0.1	(91.1)	1,197.8	(389.4)	(394.5)	322.9	11.6		554.9	49.5	(24.2)	1,459	(544)	(397)	543.3	11.6
Contributions from parent										0
Net income (loss)	(169.2)								(169.2)	(140.9)
Foreign currency translation adjustments	(5.9)								(5.9)	(5.9)
Balance, end of period at Sep. 30, 2022	205.4	0.1	(95.2)	1,214.1	(561.3)	(362.9)	194.8	10.6		454.6	49.5	(24.2)	1,474.5	(687.6)	(368.2)	444	10.6
Balance, beginning of period at Mar. 31, 2022	299.4	0.1	(92.7)	1,202.9	(463.4)	(360.6)	286.3	13.1		528.9	49.5	(24.2)	1,463.9	(606.5)	(366.9)	515.8	13.1
Issuance of share based awards and share based awards compensation expense	6			6			6			5.7			5.7			5.7
Stock withholdings related to share based awards that vested during the period	(0.5)		(0.5)				(0.5)
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes and settlements	4.2					4.2	4.2			7					7	7
Net income (loss)	(72.8)				(73.4)		(73.4)	0.6		(65.3)				(65.9)		(65.9)	0.6
Foreign currency translation adjustments										(15.7)					(15.7)	(15.7)
Foreign currency translation adjustments	(15.7)					(15.7)	(15.7)
Amortization of accumulated losses for amended swap agreements	1.1					1.1	1.1			1.1					1.1	1.1
Distributions to noncontrolling interests	(3)							(3)		(3)							(3)
Balance, end of period at Jun. 30, 2022	218.7	0.1	(93.2)	1,208.9	(536.8)	(371)	208	10.7		458.7	49.5	(24.2)	1,469.6	(672.4)	(374.5)	448	10.7
Share based awards compensation expense										4.9			4.9			4.9
Issuance of share based awards and share based awards compensation expense	5.2			5.2			5.2
Stock withholdings related to vesting of share based awards	(2)		(2)				(2)
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of taxes and settlements	11.6					11.6	11.6			9.8					9.8	9.8
Net income (loss)	(23.9)				(24.5)		(24.5)	0.6	(23.9)	(14.6)				(15.2)		(15.2)	0.6
Foreign currency translation adjustments									$ (4.6)	(4.6)					(4.6)	(4.6)
Foreign currency translation adjustments	(4.6)					(4.6)	(4.6)
Amortization of accumulated losses for amended swap agreements	1.1					1.1	1.1			1.1					1.1	1.1
Distributions to noncontrolling interests	(0.7)							(0.7)		(0.7)							0.7
Balance, end of period at Sep. 30, 2022	$ 205.4	$ 0.1	$ (95.2)	$ 1,214.1	$ (561.3)	$ (362.9)	$ 194.8	$ 10.6		$ 454.6	$ 49.5	$ (24.2)	$ 1,474.5	$ (687.6)	$ (368.2)	$ 444	$ 10.6

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Operating activities
Net loss	$ (169.2)	$ (428.7)
Adjustments to reconcile net loss to cash provided by (used for) operating activities:
Depreciation	179.1	200.3
Amortization of intangible and other assets	1.9	2
Amortization of debt issuance costs	8.2	8
Amortization of accumulated losses for amended swap agreements	3.4	3.4
Share based awards compensation expense	16.2	16.6
Impairment of long-lived and other assets	107.5	7.5
(Gain) loss on disposal of assets and other	(6.4)	7.9
Loss on extinguishment of debt	0	6.5
Non-cash rent expense	(7.5)	(1.8)
Equity in loss of affiliates	7.5	22.1
Deferred income tax benefit	(1.5)	(21.1)
Distributions from equity investees	1.5	0.2
Changes in assets and liabilities and other	106	(141.5)
Net cash provided by (used for) operating activities	27.7	(42.2)
Investing activities
Additions to theatre properties and equipment	(65.3)	(57.2)
Proceeds from sale of theatre properties and equipment and other	12	2.2
Net cash used for investing activities	(53.3)	(55)
Financing activities
Restricted stock withholdings for payroll taxes	(4.1)	0
Proceeds from issuance of senior notes	0	1,170
Proceeds from other borrowings	0	9.7
Redemption of senior notes	0	(1,155)
Repayments of long-term debt	(14)	(7.2)
Payment of debt issuance costs	0	(17.3)
Fees paid related to debt refinancing	0	(2.1)
Payments on finance leases	(10.8)	(11)
Other financing activities	(3.7)	0
Net cash provided by (used for) financing activities	(32.6)	(12.9)
Effect of exchange rate changes on cash and cash equivalents	(17.2)	(2.2)
Increase (decrease) in cash and cash equivalents	(75.4)	(112.3)
Cash and cash equivalents:
Beginning of period	707.3	655.3
End of period	631.9	543
CNK
Operating activities
Net loss	(169.2)	(428.7)
Adjustments to reconcile net loss to cash provided by (used for) operating activities:
Impairment of long-lived and other assets	107.5	7.5
Equity in loss of affiliates	7.5	22.1
CUSA
Operating activities
Net loss	(140.9)	(412.8)
Adjustments to reconcile net loss to cash provided by (used for) operating activities:
Depreciation	179.1	200.3
Amortization of intangible and other assets	1.9	2
Amortization of debt issuance costs	5.6	5.4
Amortization of accumulated losses for amended swap agreements	3.4	3.4
Share based awards compensation expense	15.5	15.9
Impairment of long-lived and other assets	107.5	7.5
(Gain) loss on disposal of assets and other	(6.4)	7.9
Loss on extinguishment of debt	0	6.5
Non-cash rent expense	(7.5)	(1.8)
Equity in loss of affiliates	7.5	22.1
Deferred income tax benefit	(3.3)	(20.9)
Distributions from equity investees	1.5	0.2
Changes in assets and liabilities and other	(109.9)	139.2
Net cash provided by (used for) operating activities	47	(31.7)
Investing activities
Additions to theatre properties and equipment	(65.3)	(57.2)
Proceeds from sale of theatre properties and equipment and other	12	2.2
Net cash used for investing activities	(53.3)	(55)
Financing activities
Restricted stock withholdings for payroll taxes	(4.1)	0
Contributions received from parent	0	120
Proceeds from issuance of senior notes	0	1,170
Proceeds from other borrowings	0	9.7
Redemption of senior notes	0	(1,155)
Repayments of long-term debt	(14)	(7.2)
Payment of debt issuance costs	0	(17.3)
Fees paid related to debt refinancing	0	(2.1)
Payments on finance leases	(10.8)	(11)
Other financing activities	(3.7)	0
Net cash provided by (used for) financing activities	(32.6)	107.1
Effect of exchange rate changes on cash and cash equivalents	(17.2)	(2.2)
Increase (decrease) in cash and cash equivalents	(56.1)	18.2
Cash and cash equivalents:
Beginning of period	442.7	260.5
End of period	386.6	278.7
NCM
Adjustments to reconcile net loss to cash provided by (used for) operating activities:
Interest accrued on NCM screen advertising advances	17.5	17.7
Amortization of NCM screen advertising advances and other deferred revenues	(24.5)	(24.3)
NCM | CUSA
Adjustments to reconcile net loss to cash provided by (used for) operating activities:
Interest accrued on NCM screen advertising advances	17.5	17.7
Amortization of NCM screen advertising advances and other deferred revenues	$ (24.5)	$ (24.3)

The Company and Basis of Presen

The Company and Basis of Presentation	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
The Company and Basis of Presentation	1. The Company and Basis of Presentation Cinemark Holdings, Inc. is a holding company and its wholly-owned subsidiary is Cinemark USA, Inc. Holdings consolidates CUSA for financial statement purposes. CUSA comprises a majority of the balance of Holdings’ assets, liabilities and operating cash flows. In addition, CUSA’s revenue comprises 100 % and its operating expenses comprise nearly 100 % of Holdings’ revenue and operating expenses, respectively. These Notes to Condensed Consolidated Financial Statements include disclosures for Holdings and CUSA and their respective consolidated subsidiaries. Where it is important to distinguish between the entities, this report either refers specifically to Holdings or CUSA. Otherwise, all references to “we,” “our,” “us,” “the Company” or "Cinemark" relate to Cinemark Holdings, Inc. and its consolidated subsidiaries and all references to CUSA relate to CUSA and its consolidated subsidiaries. The Company and its subsidiaries operate in the motion picture exhibition industry, with theatres in the United States (“U.S.”), Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay. The accompanying condensed consolidated balance sheets of Holdings and CUSA as of December 31, 2021 , each of which were derived from audited financial statements, and the unaudited condensed consolidated financial statements of Holdings and CUSA, respectively, has been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete consolidated financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation have been included. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and the accompanying notes. Actual results could differ from these estimates. Majority-owned subsidiaries over which the Company has control are consolidated while those investments in entities of which Holdings or CUSA, as applicable, owns between 20 % and 50 % and does not control are accounted for under the equity method. Investments in entities of which Holdings or CUSA, as applicable, owns less than 20 % are generally accounted for under the cost method, unless Holdings or CUSA, as applicable, is deemed to have the ability to exercise significant influence over the entities, in which case Holdings or CUSA, as applicable, would account for its investment under the equity method. The results of these subsidiaries and entities are included in the condensed consolidated financial statements effective with their formation or from their dates of acquisition. Intercompany balances and transactions are eliminated in consolidation. These condensed consolidated financial statements should be read in conjunction with the audited annual consolidated financial statements and the notes thereto for the year ended December 31, 2021, included in the Annual Report on Form 10-K filed February 25, 2022 by Holdings and the Annual Report on Form 10-K filed March 9, 2022 by CUSA, as applicable, each under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results to be achieved for the full year. Amounts included in the condensed consolidated financial statements of this Quarterly Report on Form 10-Q are rounded in millions with the exception of per share data. The amounts reported in the consolidated financial statements, and the notes thereto, of the Annual Report on Form 10-K for the year ended December 31, 2021 filed by Holdings on February 25, 2022 and by CUSA on March 9, 2022 are rounded in thousands.

Impact of COVID-19 Pandemic

Impact of COVID-19 Pandemic	9 Months Ended
	Sep. 30, 2022
Unusual or Infrequent Items, or Both [Abstract]
Impact of COVID-19 Pandemic	2. Impact of the COVID-19 Pandemic The COVID-19 pandemic has had an unprecedented impact on the world and the movie exhibition industry with widespread social and economic effects. The Company temporarily closed its theatres in the U.S. and Latin America during March of 2020 at the onset of the COVID-19 outbreak. During that time, the Company implemented various cash preservation strategies, including, but not limited to, temporary personnel and salary reductions, halting non-essential operating and capital expenditures, negotiating modified timing and/or abatement of contractual payments with landlords and other major suppliers, and suspending quarterly dividends paid by Holdings to its shareholders. Throughout 2020 and 2021 the Company reopened theatres as local restrictions and the status of the COVID-19 pandemic would allow. All of the Company's domestic and international theatres were reopened by the end of the fourth quarter of 2021. The industry’s recovery from the COVID-19 pandemic is still underway and is contingent upon the volume of new film content available, as well as the box office performance of new film content released, consumer sentiment around movie-going and government restrictions. The industry is also adjusting to the evolution of the exclusive theatrical window, competition from streaming platforms, supply chain constraints, inflationary impacts and other economic factors. Restructuring Charges During June 2020, Company management approved and announced a restructuring plan to realign its operations to create a more efficient cost structure (referred to herein as the “Restructuring Plan”) in response to the COVID-19 pandemic. The Restructuring Plan primarily included a headcount reduction at its domestic corporate office and the permanent closure of certain domestic and international theatres. The Company paid approximately $ 0.9 related to previously accrued restructuring costs during the nine months ended September 30, 2022. The Company recorded a $ 0.2 reduction to previously accrued restructuring costs during the nine months ended September 30, 2022 related to the settlement of facility closure costs for certain theatres. The remaining accrued restructuring costs of $ 0.4 , which are primarily related to facility closure costs, are reflected in accounts payable and accrued expenses on the condensed consolidated balance sheet as of September 30, 2022 .

New Accounting Pronouncements

New Accounting Pronouncements	9 Months Ended
	Sep. 30, 2022
Accounting Changes and Error Corrections [Abstract]
New Accounting Pronouncements	3. New Accounting Pronouncements Accounting Standards Update (“ASU”) 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting , (“ASU 2020-04”) and ASU 2021-01, Reference Rate Reform (Topic 848): Scope , (“ASU 2021-01”). The purpose of ASU 2020-04 is to provide optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. More specifically, the amendments in ASU 2020-04 provide optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in ASU 2021-01 clarify that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition. The amendments in ASU 2020-04 and ASU 2021-01 are effective as of March 12, 2020 through December 31, 2022. The Company does not expect ASU 2020-04 and ASU 2021-01 to have a material impact on the condensed consolidated financial statements of Holdings or CUSA. ASU 2021-10, Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance , (“ASU 2021-10”). The purpose of ASU 2021-10 is to provide annual disclosure guidance about transactions with a government for which the entity is applying a grant or contribution accounting model by analogy. More specifically, the amendments in ASU 2021-10 require disclosure of a) the nature of the transactions and the related accounting policy used to account for the transactions, b) the line items on the balance sheet and statement of loss, including the amounts applicable to each line item, that are affected by the transactions and c) significant terms and conditions of the transactions, including commitments and contingencies. The amendments in ASU 2021-10 are effective for annual periods beginning after December 15, 2021. The amendments in ASU 2021-10 should be applied either a) prospectively to all transactions at the date of initial application and new transactions that are entered into after the date of initial application or b) retrospectively to those transactions. Holdings and CUSA will provide the disclosures required by ASU 2021-10 in the Form 10-K for the year ended December 31, 2022.

Lease Accounting

Lease Accounting	9 Months Ended
	Sep. 30, 2022
Leases [Abstract]
Lease Accounting	4. Lease Accounting Lease Deferrals and Abatements Upon the temporary closure of theatres in March 2020, the Company began negotiating the deferral of rent and other lease-related payments with its landlords while theatres remained closed. These negotiations resulted in amendments to the leases that involved varying concessions, including the abatement of rent payments during closure, deferral of all or a portion of rent payments to later periods, temporary percentage rent terms and deferrals of rent payments combined with an early exercise of an existing renewal option or extension of the lease term. Total remaining deferred payments as of September 30, 2022 and December 31, 2021 were $ 5.3 and $ 31.9 , respectively, and are included in accounts payable and accrued expenses in the condensed consolidated balance sheets. The following table represents the Company’s aggregate lease costs, by lease classification, for the periods presented. Three Months Ended Nine Months Ended September 30, September 30, Lease Cost Classification 2022 2021 2022 2021 Operating lease costs Equipment (1) Utilities and other $ 1.0 $ 0.7 $ 2.6 $ 1.6 Real Estate (2)(3) Facility lease expense 79.5 69.5 236.4 200.9 Total operating lease costs $ 80.5 $ 70.2 $ 239.0 $ 202.5 Finance lease costs Amortization of leased assets Depreciation and amortization $ 3.1 $ 3.1 $ 9.4 $ 9.5 Interest on lease liabilities Interest expense 1.4 1.4 4.1 4.5 Total finance lease costs $ 4.5 $ 4.5 $ 13.5 $ 14.0 (1) Includes approximately $ 0.8 and $ 0.6 of short-term lease payments for the three months ended September 30, 2022 and 2021, respectively. Includes approximately $ 2.2 and $ 1.2 of short-term lease payments for the nine months ended September 30, 2022 and 2021 , respectively. (2) Includes approximately $ 9.4 and $ 1.9 of variable lease payments based on a change in index, such as CPI or inflation, variable payments based on revenue or attendance and variable common area maintenance costs for the three months ended September 30, 2022 and 2021, respectively. Includes approximately $ 27.5 and $ ( 0.1 ) of variable lease payments based on a change in index, such as CPI or inflation, variable payments based on revenue or attendance and variable common area maintenance costs for the nine months ended September 30, 2022 and 2021 , respectively. (3) Approximately $ 0.3 and $ 0.3 of lease payments are included in general and administrative expense prim arily related to office leases for the three months ended September 30, 2022 and 2021, respectively. Approximately $ 1.0 and $ 1.0 of lease payments are included in general and administrative expense prim arily related to office leases for the nine months ended September 30, 2022 and 2021 , respectively. The following table represents the minimum cash lease payments included in the measurement of lease liabilities and the non-cash addition of lease right-of-use assets for the periods presented. Nine Months Ended September 30, Other Information 2022 2021 Cash paid for amounts included in the measurement of lease liabilities Cash outflows for operating leases $ 209.3 $ 201.4 Cash outflows for finance leases - operating activities $ 4.1 $ 4.5 Cash outflows for finance leases - financing activities $ 10.8 $ 11.0 Non-cash amount of right-of-use assets obtained in exchange for: Operating lease liability additions, net of write-offs $ 78.5 $ 109.1 As of September 30, 2022 , the Company had signed lease agreements with total noncancelable lease payments of approximately $ 69.3 related to theatre leases that had not yet commenced. The timing of lease commencement is dependent on the completion of construction of the related theatre facility. Additionally, these amounts are based on estimated square footage and costs to construct each facility and may be subject to adjustment upon final completion of each construction project. In accordance with ASC Topic 842, fixed minimum lease payments related to these theatres are not included in the right-of-use assets and lease liabilities as of September 30, 2022 .

Revenue Recognition

Revenue Recognition	9 Months Ended
	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Revenue Recognition	5. Revenue Recognition The Company’s patrons have the option to purchase movie tickets well in advance of a movie showtime or right before the movie showtime, or at any point in between those two timeframes depending on seat availability. The Company recognizes such admissions revenue when the showtime for a purchased movie ticket has passed. Concession revenue is recognized when products are sold to the consumer. Other revenue primarily consists of screen advertising and screen rental revenue, promotional income, studio trailer placements and transactional fees. Except for National CineMedia, LLC. ("NCM") screen advertising advances discussed below in Note 8, these revenues are generally recognized when the Company has performed the related services. The Company sells gift cards and discount ticket vouchers, the proceeds from which are recorded as deferred revenue. Deferred revenue for gift cards and discount ticket vouchers is recognized when they are redeemed for concession items or, if redeemed for movie tickets, when the showtime has passed. The Company generally records breakage revenue on gift cards and discount ticket vouchers based on redemption activity and historical experience with unused balances. The Company offers a subscription program in the U.S. whereby patrons can pay a monthly or annual fee to receive a monthly credit for use towards a future movie ticket purchase. The Company records the subscription program fees as deferred revenue and records admissions revenue when the showtime for a movie ticket purchased with a credit has passed. The Company has loyalty programs in the U.S. and many of its international locations that either have a prepaid annual fee or award points to customers as purchases are made. For those loyalty programs that have a prepaid annual fee, the Company recognizes the fee collected as other revenue on a straight-line basis. For those loyalty programs that award points to customers based on their purchases, the Company records a portion of the original transaction proceeds as deferred revenue based on the number of reward points issued to customers and recognizes the deferred revenue when the customer redeems such points. The value of loyalty points issued is based on the estimated fair value of the rewards offered. The Company records breakage revenue on its loyalty and subscription programs generally upon the expiration of loyalty points or subscription credits. Advances collected on other contracts are deferred and recognized during the period in which the Company satisfies the related performance obligations, which may differ from the period in which the advances are collected. Accounts receivable as of September 30, 2022 and December 31, 2021 included approximately $ 19.4 and $ 23.5 , respectively, of receivables related to contracts with customers. The Company did no t record any assets related to the costs to obtain or fulfill a contract with customers during the nine months ended September 30, 2022. Disaggregation of Revenue The following tables present revenue disaggregated based on major type of good or service and by reportable operating segment. Three Months Ended Nine Months Ended September 30, 2022 September 30, 2022 U.S. International U.S. International Operating Operating Operating Operating Segment (1) Segment Consolidated Segment (1) Segment Consolidated Admissions revenue $ 257.6 $ 67.0 $ 324.6 $ 759.1 $ 183.2 $ 942.3 Concession revenue 200.8 52.8 253.6 576.5 136.1 712.6 Screen advertising, screen rental and promotional revenue (2) 20.6 11.3 31.9 60.7 30.7 91.4 Other revenue 32.7 7.6 40.3 88.2 20.5 108.7 Total revenue $ 511.7 $ 138.7 $ 650.4 $ 1,484.5 $ 370.5 $ 1,855.0 Three Months Ended Nine Months Ended September 30, 2021 September 30, 2021 U.S. International U.S. International Operating Operating Operating Operating Segment (1) Segment Consolidated Segment (1) Segment Consolidated Admissions revenue $ 195.3 $ 30.2 $ 225.5 $ 384.4 $ 50.7 $ 435.1 Concession revenue 142.6 21.6 164.2 275.0 38.5 313.5 Screen advertising, screen rental and promotional revenue (2) 18.0 4.8 22.8 44.5 7.6 52.1 Other revenue 19.5 2.8 22.3 37.9 5.2 43.1 Total revenue $ 375.4 $ 59.4 $ 434.8 $ 741.8 $ 102.0 $ 843.8 (1) U.S. segment revenue excludes intercompany transactions with the international operating segment. See Note 16 for the amount of intercompany eliminations for the periods presented. (2) Amount includes amortization of NCM screen advertising advances. See NCM Screen Advertising Advances and Other Deferred Revenue below . The following tables present revenue disaggregated based on timing of recognition and by reportable operating segment. Three Months Ended Nine Months Ended September 30, 2022 September 30, 2022 U.S. International U.S. International Operating Operating Operating Operating Segment (1) Segment Consolidated Segment (1) Segment Consolidated Goods and services transferred at a point in time $ 478.9 $ 123.8 $ 602.7 $ 1,401.0 $ 332.2 $ 1,733.2 Goods and services transferred over time (2) 32.8 14.9 47.7 83.5 38.3 121.8 Total $ 511.7 $ 138.7 $ 650.4 $ 1,484.5 $ 370.5 $ 1,855.0 Three Months Ended Nine Months Ended September 30, 2021 September 30, 2021 U.S. International U.S. International Operating Operating Operating Operating Segment (1) Segment Consolidated Segment (1) Segment Consolidated Goods and services transferred at a point in time $ 348.4 $ 53.3 $ 401.7 $ 678.4 $ 91.5 $ 769.9 Goods and services transferred over time (2) 27.0 6.1 33.1 63.4 10.5 73.9 Total $ 375.4 $ 59.4 $ 434.8 $ 741.8 $ 102.0 $ 843.8 (1) U.S. segment revenue excludes intercompany transactions with the international operating segment. See Note 16 for the amount of intercompany eliminations for the periods presented. (2) Amount includes amortization of NCM screen advertising advances. See NCM Screen Advertising Advances and Other Deferred Revenue below. NCM Screen Advertising Advances and Other Deferred Revenue The following table presents changes in the Company’s NCM screen advertising advances and other deferred revenue for the nine months ended September 30, 2022. NCM screen advertising advances (1) Other (2) Balance at January 1, 2022 $ 346.0 $ 160.3 Amounts recognized as accounts receivable — 1.0 Cash received from customers in advance — 163.5 Common units received from NCM 1.3 — Interest accrued related to significant financing component 17.5 — Revenue recognized during period ( 24.3 ) ( 150.9 ) Foreign currency translation adjustments — ( 1.0 ) Balance at September 30, 2022 $ 340.5 $ 172.9 (1) See Note 8 for the maturity of NCM screen advertising advances as of September 30, 2022 . (2) Includes liabilities associated with outstanding gift cards and discount ticket vouchers, points or rebates outstanding under the Company’s loyalty and membership programs and revenue collected but not yet earned for screen advertising, screen rental and other promotional activities. Amounts are classified as accounts payable and accrued expenses or other long-term liabilities on the condensed consolidated balance sheet. The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied as of September 30, 2022 and when the Company expects to recognize this revenue. Twelve Months Ended September 30, Remaining Performance Obligations 2023 2024 Thereafter Total Other deferred revenue $ 153.3 $ 19.6 $ — $ 172.9

Earnings Per Share

Earnings Per Share	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Earnings Per Share	6. Earnings Per Share The following table presents computations of basic and diluted loss per share for Holdings: Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 Numerator: Net loss attributable to Cinemark Holdings, Inc. $ ( 24.5 ) $ ( 77.8 ) $ ( 171.9 ) $ ( 428.5 ) Loss allocated to participating share-based awards (1) 0.4 1.5 2.4 7.6 Net loss attributable to common stockholders $ ( 24.1 ) $ ( 76.3 ) $ ( 169.5 ) $ ( 420.9 ) Denominator : Basic weighted average shares outstanding 118.4 117.3 118.1 117.2 Common equivalent shares for restricted stock units (2) — — — — Common equivalent shares for convertible notes and warrants (3) — — — — Diluted weighted average shares outstanding 118.4 117.3 118.1 117.2 Basic loss per share attributable to common stockholders $ ( 0.20 ) $ ( 0.65 ) $ ( 1.43 ) $ ( 3.59 ) Diluted loss per share attributable to common stockholders $ ( 0.20 ) $ ( 0.65 ) $ ( 1.43 ) $ ( 3.59 ) (1) For the three months ended September 30, 2022 and 2021, a weighted average of approximately 1.90 shares and 2.34 shares of restricted stock, respectively, were considered participating securities. For the nine months ended September 30, 2022 and 2021, a weighted average of approximately 1.69 shares and 2.11 shares of restricted stock, respectively, were considered participating securities. (2) For the three months ended September 30, 2022 and 2021 , approximately 0.18 and 0.10 common equivalent shares for restricted stock units, respectively, were excluded because they were anti-dilutive. For the nine months ended September 30, 2022 and 2021 , approximately 0.39 and 0.10 common equivalent shares for restricted stock units, respectively, were excluded because they were anti-dilutive. (3) For the three and nine months ended September 30, 2022 and 2021, diluted loss per share excludes the conversion of the 4.50 % Convertible Senior Notes into 32.0 shares of common stock, as well as outstanding warrants, as they would be anti-dilutive. See further discussion below. Share-based awards Holdings considers its unvested share-based payment awards, which contain non-forfeitable rights to dividends, participating securities, and includes such participating securities in its computation of loss per share pursuant to the two-class method. Basic loss per share for the two classes of stock (common stock and unvested restricted stock) is calculated by dividing net loss by the weighted average number of shares of common stock and unvested restricted stock outstanding during the reporting period. Diluted loss per share is calculated using the weighted average number of shares of common stock plus the potentially dilutive effect of common equivalent shares outstanding determined under both the two-class method and the treasury stock method. Convertible notes, hedges and warrants The 4.50% Convertible Senior Notes, discussed further in Note 13 of Holdings' Annual Report on Form 10-K filed February 26, 2021, may be considered dilutive in future periods in which Holdings has net income. The impact of such dilution on earnings per share will be calculated under the if-converted method, which requires that all of the shares of Holdings' common stock issuable upon conversion of the 4.50% Convertible Senior Notes be included in the calculation of diluted EPS assuming conversion at the beginning of the reporting period. The closing price of Holdings' common stock did not exceed the strike price of $ 18.65 per share ( 130 % of the initial exercise price of $ 14.35 per share) during at least 20 of the last 30 trading days of the nine months ended September 30, 2022 and, therefore, the 4.50% Convertible Senior Notes are not convertible during the fourth quarter of 2022. The if-converted value of the 4.50% Convertible Senior Notes exceeded the aggregate outstanding principal value of the notes by $ 54.3 as of September 30, 2022. Holdings entered into hedge transactions with counterparties in connection with the issuance of the 4.50% Convertible Senior Notes. The convertible note hedge transactions cover, subject to anti-dilution adjustments substantially similar to those applicable to 4.50% Convertible Senior Notes, the number of shares of Holdings' common stock underlying the 4.50% Convertible Notes, which initially gives Holdings the option to purchase approximately 32.0 shares of its common stock at a price of approximately $ 14.35 per share. Concurrently with entering into the convertible note hedge transactions, Holdings also entered into warrant transactions with each option counterparty whereby Holdings sold to such option counterparty warrants to purchase, subject to customary anti-dilution adjustments, up to the same number of shares of Holdings' common stock, which initially gives the option counterparties the option to purchase approximately 32.0 million shares at a price of approximately $ 22.08 per share. The economic effect of these transactions is to effectively raise the strike price of the 4.50% Convertible Senior Notes from approximately $18.65 per share of Holdings' common stock to approximately $ 22.08 per share.

Long Term Debt

Long Term Debt	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Long Term Debt Activity	7. Long Term Debt Long-term debt of Holdings consisted of the following for the periods presented: September 30, December 31, 2022 2021 Cinemark Holdings, Inc. 4.500% convertible senior notes due 2025 $ 460.0 $ 460.0 Cinemark USA, Inc. term loan due 2025 628.2 633.1 Cinemark USA, Inc. 8.750% senior secured notes due 2025 250.0 250.0 Cinemark USA, Inc. 5.875% senior notes due 2026 405.0 405.0 Cinemark USA, Inc. 5.250% senior notes due 2028 765.0 765.0 Other 21.9 30.2 Total carrying value of long-term debt $ 2,530.1 $ 2,543.3 Less: Current portion 22.0 24.3 Less: Debt issuance costs, net of accumulated amortization 34.6 42.7 Long-term debt, less current portion, net of unamortized debt issuance costs $ 2,473.5 $ 2,476.3 Long-term debt of CUSA consisted of the following for the periods presented: September 30, December 31, 2022 2021 Cinemark USA, Inc. term loan due 2025 $ 628.2 $ 633.1 Cinemark USA, Inc. 8.750% senior secured notes due 2025 250.0 250.0 Cinemark USA, Inc. 5.875% senior notes due 2026 405.0 405.0 Cinemark USA, Inc. 5.250% senior notes due 2028 765.0 765.0 Other 21.9 30.2 Total carrying value of long-term debt $ 2,070.1 $ 2,083.3 Less: Current portion 22.0 24.3 Less: Debt issuance costs, net of accumulated amortization 24.7 30.3 Long-term debt, less current portion, net of unamortized debt issuance costs $ 2,023.4 $ 2,028.7 Senior Secured Credit Facility CUSA has a senior secured credit facility that includes a $ 700.0 term loan and a $ 100.0 revolving credit line (the “Credit Agreement”) which is guaranteed by Holdings. As of September 30, 2022 , there was $ 628.2 outstanding under the term loan and no borrowings were outstanding under the revolving credit line. As of September 30, 2022 , $ 100.0 was available for borrowing under the revolving credit line. Quarterly principal payments of $ 1.6 are due on the term loan through December 31, 2024 , with a final principal payment of $ 613.4 due on March 29, 2025 . The revolving credit line matures on November 28, 2024 . The average interest rate on outstanding term loan borrowings under the Credit Agreement as of September 30, 2022 was approximately 4.1 % per annum, after giving effect to the interest rate swap agreements discussed below. Interest Rate Swap Agreements Below is a summary of the Company's interest rate swap agreements, which are designated as cash flow hedges, as of September 30, 2022: Notional Estimated Amount Effective Date Pay Rate Receive Rate Expiration Date Fair Value (1) $ 137.5 December 31, 2018 2.12 % 1-Month LIBOR December 31, 2024 $ 6.1 $ 175.0 December 31, 2018 2.12 % 1-Month LIBOR December 31, 2024 8.0 $ 137.5 December 31, 2018 2.19 % 1-Month LIBOR December 31, 2024 6.1 Total $ 20.2 (1) Approximately $ 9.9 of the total is included in prepaid expenses and other and $ 10.3 is included in deferred charges and other assets, net on the condensed consolidated balance sheet as of September 30, 2022 . Effective March 31, 2020, the Company amended and extended its three then existing interest rate swap agreements, all of which are used to hedge a portion of the interest rate risk associated with the variable interest rates on its term loan debt and qualify for cash flow hedge accounting. Upon amending the interest rate swap agreements effective March 31, 2020, the Company determined that the interest payments hedged with the agreements are still probable to occur, therefore the loss that accumulated on the swaps prior to the amendments is being amortized to interest expense through December 31, 2022, the original maturity dates of the swaps. Approximately $ 1.1 was recorded in interest expense in the condensed consolidated statements of loss for the three months ended September 30, 2022 and 2021 and $ 3.4 was recorded in interest expense in the condensed consolidated statements of loss for the nine months ended September 30, 2022 and 2021. The fair values of the interest rate swaps are recorded on Holdings' and CUSA's condensed consolidated balance sheets as an asset or liability with the related gains or losses reported as a component of accumulated other comprehensive loss. The changes in fair value are reclassified from accumulated other comprehensive loss into earnings in the same period that the hedged items affect earnings. The valuation technique used to determine fair value is the income approach and, under this approach, the Company used projected future interest rates as provided by counterparties to the interest rate swap agreements and the fixed rates that the Company is obligated to pay under the agreement. Therefore, the Company's measurements use significant unobservable inputs, which fall in Level 2 of the U.S. GAAP hierarchy as defined by FASB ASC Topic 820-10-35. Fair Value of Long-Term Debt The Company estimates the fair value of its long-term debt primarily using quoted market prices, which fall under Level 2 of the U.S. GAAP fair value hierarchy as defined by ASC 820, Fair Value Measurement (“ASC Topic 820”) . The table below presents the fair value of the Company's long-term debt as of the periods presented: As of September 30, 2022 December 31, 2021 Holdings fair value (1) $ 2,326.2 $ 2,749.8 CUSA fair value $ 1,798.7 $ 2,058.0 (1) Includes the fair value of the 4.500 % convertible senior notes of $ 527.5 and $ 691.9 as of September 30, 2022 and December 31, 2021, respectively.

Investment in National CineMedi

Investment in National CineMedia LLC	9 Months Ended
	Sep. 30, 2022
Investment in National CineMedia LLC	8. Investment in National CineMedia LLC Below is a summary of activity with NCM included in each of Holdings' and CUSA's condensed consolidated financial statements: Investment NCM Screen Advertising Advances Equity in Other Interest Cash (2) Balance as of January 1, 2022 $ 135.4 $ ( 346.0 ) Receipt of common units due to annual common unit adjustment ("CUA") 1.3 ( 1.3 ) Screen rental revenue earned under ESA (1) — — $ — $ ( 15.0 ) $ — $ 15.0 Interest accrued related to significant financing component — ( 17.5 ) — — 17.5 — Equity in loss ( 10.3 ) — 10.3 — — — Impairment of investment in NCM ( 98.0 ) — — — — — Amortization of screen advertising advances — 24.3 — ( 24.3 ) — — Balance as of and for the nine months ended September 30, 2022 $ 28.4 $ ( 340.5 ) $ 10.3 $ ( 39.3 ) $ 17.5 $ 15.0 (1) Amounts include the per patron and per digital screen theatre access fees due to CUSA, net of amounts due to NCM for on-screen advertising time provided to the Company's beverage concessionaire of approximately $ 5.9 . (2) The Company had a receivable from NCM of $ 5.1 as of September 30, 2022 . Investment in National CineMedia NCM operates a digital in-theatre network in the U.S. for providing cinema advertising. The Company entered into an Exhibitor Services Agreement with NCM (“ESA”), pursuant to which NCM primarily provides advertising to our theatres. See Note 8 to Holdings' Annual Report on Form 10-K filed February 25, 2022 and Note 6 to CUSA's Annual Report on From 10-K filed March 9, 2022 for additional discussion of the Company's investment in NCM as well as the accounting for its original NCM membership units and subsequent common unit adjustments. Common Unit Adjustments The Company also periodically receives consideration in the form of common units from NCM. Annual adjustments to the common membership units are made primarily based on increases or decreases in the number of theatre screens operated and the impact of these theatres on total attendance. The common units received are recorded at estimated fair value as an increase in the Company's investment in NCM with an offset to NCM screen advertising advances. During March 2022, NCM performed its annual common unit adjustment calculation under the Common Unit Adjustment Agreement. As a result of the calculation, the Company received an additional 0.5 common units of NCM during April 2022 and recorded the additional common units received at their estimated fair value of $ 1.3 with a corresponding adjustment to NCM screen advertising advances. The fair value of the common units received was estimated based on the market price of National Cinemedia, Inc. ("NCMI") common stock (Level 1 input as defined in FASB ASC Topic 820) at the time the common units were determined, adjusted for volatility associated with the estimated time period it would take to convert the common units and register the respective shares. Impairment of NCM Investment As of September 30, 2022, the Company owned a total of 43.7 common units of NCM representing an ownership interest of approximately 25.5 %. Each of the Company’s common units in NCM is convertible into one share of NCMI common stock. As of September 30, 2022, the estimated fair value of the Company’s investment in NCM was approximately $ 28.4 based on NCMI's stock price as of September 30, 2022 of $ 0.65 per share (Level 1 input as defined in FASB ASC Topic 820). Because the share price of NCMI was significantly below the Company’s carrying value of NCM per common unit and due to the prolonged recovery of NCM's business, the Company wrote down its investment in NCM to its estimated fair value during the nine months ended September 30, 2022. See Note 12 for impairment expense recorded during the three and nine months ended September 30, 2022 and 2021. Exhibitor Services Agreement As discussed above, the Company’s domestic theatres are part of the in-theatre digital network operated by NCM, the terms of which are defined in the ESA. NCM provides advertising to its theatres through its branded “ Noovie ” pre-show entertainment program and also handles lobby promotions and displays for our theatres. The Company receives a monthly theatre access fee for participation in the NCM network and also earns screen advertising or screen rental revenue on a per patron basis. See Note 8 to Holdings' Annual Report on Form 10-K filed February 25, 2022 and Note 6 to CUSA's Annual Report on Form 10-K filed March 9, 2022 for further discussion of the accounting for revenue earned under the ESA as well as the accounting related to NCM screen advertising advances. The deferred NCM screen advertising advances are recorded on a straight-line basis over the term of the amended ESA through February 2041. The table below summarizes when the Company expects to recognize this revenue: Twelve Months Ended September 30, Remaining Maturity 2023 2024 2025 2026 2027 Thereafter Total NCM screen advertising advances (1) $ 9.6 $ 10.3 $ 11.0 $ 11.8 $ 12.6 $ 285.2 $ 340.5 (1) Amounts are net of the estimated interest to be accrued for the periods presented. See discussion of significant financing component below. Significant Financing Component As discussed in Note 8 to Holdings' Annual Report on Form 10-K filed February 25, 2022 and Note 6 to CUSA's Annual Report on Form 10-K filed March 9, 2022, CUSA's ESA with NCM includes an implied significant financing component, as per the guidance in ASC Topic 606. As a result of the significant financing component, the Company recognized incremental screen rental revenue and interest expense of $ 24.3 and $ 17.5 , respectively, during the nine months ended September 30, 2022 and incremental screen rental revenue and interest expense of $ 24.0 and $ 17.7 , respectively, during the nine months ended September 30, 2021 . The interest expense was calculated using the Company's incremental borrowing rates at the time when the cash was received from the NCM, Inc. IPO and each tranche of common units was received from NCM, which ranged from 4.4 % to 8.3 %. NCM Financial Information Below is summary financial information for NCM for the periods indicated: Three Months Ended Three Months Ended Nine Months Ended Nine Months Ended September 29, 2022 September 30, 2021 September 29, 2022 September 30, 2021 Gross revenue $ 54.5 $ 31.7 $ 157.5 $ 51.1 Operating loss $ ( 4.3 ) $ ( 18.7 ) $ ( 21.2 ) $ ( 76.6 ) Net loss $ ( 24.4 ) $ ( 35.3 ) $ ( 79.0 ) $ ( 125.7 ) As of As of September 29, 2022 December 30, 2021 Current assets $ 123.5 $ 115.4 Noncurrent assets $ 637.5 $ 658.0 Current liabilities $ 72.7 $ 67.2 Noncurrent liabilities $ 1,162.4 $ 1,114.7 Members deficit $ ( 474.1 ) $ ( 408.5 )

Other Investments

Other Investments	9 Months Ended
	Sep. 30, 2022
Financial Support for Nonconsolidated Legal Entity [Abstract]
Other Investments	9. Other Investments Digital Cinema Implementation Partners LLC (“DCIP”) On February 12, 2007, the Company, AMC and Regal (the “Exhibitors”) entered into a joint venture known as DCIP to facilitate the implementation of digital cinema in the Company’s theatres and to establish agreements with major motion picture studios for the financing of digital cinema. As of September 30, 2022 , the Company had a 33 % voting interest in DCIP and a 24.3 % economic interest in DCIP. DCIP also entered into long-term Digital Cinema Deployment Agreements (“DCDAs”) with six major motion picture studios pursuant to which Kasima LLC, one of DCIP’s subsidiaries, received a virtual print fee ("VPF") each time the studio booked a film or certain other content on the leased digital projection systems. Other content distributors entered into similar DCDAs that provided for the payment of VPFs for bookings of the distributor's content on a leased digital projection system. The DCDAs expired in October 2021. Pursuant to the operating agreement between the Exhibitors and DCIP, DCIP began to distribute excess cash generated from their operations to the Exhibitors during 2019. As the DCDAs have expired and the MELA (as defined below) has been terminated, as discussed below, DCIP and its subsidiaries no longer have regular operations, and a final distribution was made during July 2022. Effective November 1, 2020, the Company amended the master equipment lease agreement (“MELA”) with Kasima LLC, which is an indirect subsidiary of DCIP, resulting in the termination of the MELA. Upon termination of the MELA, the Company received a distribution of the digital projection equipment that it previously leased. As the fair value of the distributed projectors was greater than the Company's investment in DCIP at the time of the distribution, the investment in DCIP was reduced to zero at the time of the distribution. The Company does not recognize undistributed equity in the earnings or loss of its investment in DCIP until such time that future net earnings, less distributions received, surpass the amount of the excess distribution. The investment in DCIP on the condensed consolidated balance sheets of Holdings and CUSA as of December 31, 2021 and September 30, 2022 was $ 0 . DCIP ceased operations at the end of the second quarter of 2022. The Company received distributions and warranty reimbursements from DCIP for the three and nine months ended September 30, 2022 and 2021 as follows: Three Months Ended Nine Months Ended Transactions September 30, 2022 September 30, 2021 September 30, 2022 September 30, 2021 Warranty reimbursements (1) $ — $ ( 0.1 ) $ — $ ( 0.8 ) Distributions from DCIP (2) $ 3.7 $ 6.5 $ 3.7 $ 6.5 (1) Recorded as a reduction of utilities and other costs on the condensed consolidated statements of loss. (2) Cash distributions received from DCIP are not treated as a reduction of the investment balance because, as discussed above, the Company's equity investment in DCIP is zero. Reflected as distributions from DCIP on the condensed consolidated statements of loss. Other Investment Activity Below is a summary of activity for each of the Company’s other investees and corresponding changes to the Company's investment balances during the nine months ended September 30, 2022: AC JV, DCDC FE Concepts Other Total Balance at January 1, 2022 $ 3.7 $ 1.8 $ 19.3 $ 0.4 $ 25.2 Cash distributions received ( 1.5 ) — — — ( 1.5 ) Equity income 1.6 0.1 1.1 — 2.8 Other — — — ( 0.2 ) ( 0.2 ) Balance at September 30, 2022 $ 3.8 $ 1.9 $ 20.4 $ 0.2 $ 26.3 Transactions with Other Investees Below is a summary of transactions with each of the Company’s other investees for the three and nine months ended September 30, 2022 and 2021: Three Months Ended Nine Months Ended Investee Transactions September 30, 2022 September 30, 2021 September 30, 2022 September 30, 2021 AC JV, LLC Event fees paid (1) $ 2.1 $ 0.8 $ 6.6 $ 1.4 DCDC Content delivery fees paid (1) $ 0.1 $ 0.2 $ 0.4 $ 0.4 (1) Included in film rentals and advertising costs on the condensed consolidated statements of loss.

Treasury Stock and Share Based

Treasury Stock and Share Based Awards	9 Months Ended
	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Treasury Stock and Share Based Awards	10. Treasury Stock and Share Based Awards Treasury Stock - Holdings Treasury stock represents shares of common stock repurchased or withheld by Holdings and not yet retired. The Company has applied the cost method in recording its treasury shares. Below is a summary of treasury stock activity for the nine months ended September 30, 2022: Number of Treasury Shares Cost Balance at January 1, 2022 5.35 $ 91.1 Restricted stock withholdings (1) 0.24 4.1 Restricted stock forfeitures 0.07 — Balance at September 30, 2022 5.66 $ 95.2 (1) Holdings withheld shares as a result of the election by certain employees to satisfy their tax liabilities upon vesting of restricted stock and restricted stock units. Holdings determined the number of shares to be withheld based upon market values of the common stock of Holdings on the vest dates, which ranged from $ 15.18 to $ 18.33 per share. As of September 30, 2022, Holdings had no plans to retire any shares of treasury stock. Restricted Stock Below is a summary of restricted stock activity for the nine months ended September 30, 2022: Shares of Weighted Restricted Grant Date Stock Fair Value Outstanding at January 1, 2022 2.00 $ 21.73 Granted 0.88 $ 16.40 Vested ( 0.90 ) $ 19.00 Forfeited ( 0.07 ) $ 18.80 Outstanding at September 30, 2022 1.91 $ 20.66 Unvested restricted stock at September 30, 2022 1.91 $ 20.66 Nine Months Ended 2022 2021 Compensation expense recognized during the period CUSA employees $ 11.3 $ 13.1 Holdings directors 0.7 0.7 Total recognized by Holdings $ 12.0 $ 13.8 Fair value of vested restricted stock held by: CUSA employees $ 14.6 $ 1.2 Holdings directors 0.6 1.3 Holdings total $ 15.2 $ 2.5 Income tax benefit (cost) related to vested restricted stock held by: CUSA employees $ 2.4 $ ( 0.4 ) Holdings directors 0.1 0.3 Holdings total income tax benefit (cost) $ 2.5 $ ( 0.1 ) During the nine months ended September 30, 2022, Holdings granted 0.88 shares of its restricted stock to certain CUSA employees and its directors. The fair value of the restricted stock granted was determined based on the closing price of Holdings' common stock on the grant dates, which ranged from $ 13.36 to $ 17.07 per share. Holdings assumed forfeiture rates for the restricted stock awards that ranged from 0 % to 12 %. The restricted stock granted during the nine months ended September 30, 2022 vests over periods ranging from one to three years. The recipients of restricted stock are entitled to receive non-forfeitable dividends and to vote their respective shares, however, the sale and transfer of the restricted shares is prohibited during the restriction period. As of September 30, 2022, the estimated remaining unrecognized compensation expense related to unvested restricted stock awards was as follows: Estimated Remaining Expense CUSA employees (1) $ 23.0 Holdings directors 0.8 Total remaining - Holdings (1) $ 23.8 (1) The weighted average period over which this remaining compensation expense will be recognized by both Holdings and CUSA is approximately 2 years. Restricted Stock Units Below is a summary of restricted stock unit activity for the periods presented: Nine Months Ended September 30, 2022 2021 Number of restricted stock units that vested during the period 0.10 0.01 Fair value of restricted stock units that vested during the period $ 1.7 $ 0.3 Accumulated dividends paid upon vesting of restricted stock units $ 0.3 $ 0.1 Compensation expense recognized during the period $ 4.2 $ 2.8 Income tax benefit (cost) related to restricted stock units $ 0.1 $ ( 0.5 ) During the nine months ended September 30, 2022, Holdings granted performance awards in the form of restricted stock units. The maximum number of shares issuable under the performance awards is 0.8 shares of Holdings' common stock. The performance metrics for these awards are based upon the achievement of pre-established criteria that consists of revenue and consolidated cash flows as defined in the award agreement. The performance measurement period for these performance awards is one year with an additional service requirement to the third anniversary of the date of grant. Each performance target underlying the performance award has a threshold, target and maximum level, with the maximum level equal to 175% of the target award. If the performance metrics meet the threshold level, approximately 29% of the maximum restricted stock units vest. If the performance metrics for the one-year period are at target, approximately 57% of the maximum restricted stock units vest. If the performance metrics are at the maximum, 100% of the maximum restricted stock units vest. Grantees are eligible to receive a ratable portion of the common stock issuable if the achievement of the performance goals is within the targets previously noted. All restricted stock units granted during 2022 will be paid in the form of Holdings' common stock if the participant continues to provide services through the third anniversary of the grant date. Restricted stock unit award participants are eligible to receive dividend equivalent payments from the grant date to the extent declared by Holdings if, and at the time that, the restricted stock unit awards vest. When the performance awards were issued, the Company estimated that the most likely outcome is the achievement of the target level. The fair value of the restricted stock unit awards was determined based on the closing price of Holdings' common stock on the date of grant, which was $ 16.65 per share. The Company assumed a forfeiture rate of 5 % for the restricted stock unit awards. Based on updated performance expectations, the Company determined that the maximum performance level was more likely to be achieved. The Company recorded incremental compensation expense of approximately $ 0.6 related to the change in estimated performance level during the nine months ended September 30, 2022. As of September 30, 2022 , the estimated remaining unrecognized compensation expense related to outstanding restricted stock units was $ 12.0 . The weighted average period over which this remaining compensation expense will be recognized is approximately two years . As of September 30, 2022 , Holdings had restricted stock units outstanding that represented a total of 1.0 hypothetical shares of common stock, net of forfeitures, reflecting actual certified performance levels for restricted stock units granted during 2019 and 2020 and the maximum performance level for the 2022 grant as discussed above, adjusted for estimated forfeitures.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	9 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	11. Goodwill and Other Intangible Assets A summary of the Company's goodwill is as follows: U.S. International Total Balance at January 1, 2022 (1) $ 1,182.9 $ 65.9 $ 1,248.8 Foreign currency translation adjustments — 0.4 0.4 Balance at September 30, 2022 (1) $ 1,182.9 $ 66.3 $ 1,249.2 (1) Balances are presented net of accumulated impairment losses of $ 214.0 for the U.S. operating segment and $ 43.8 for the international operating segment. See discussion of the qualitative impairment analysis performed by the Company as of September 30, 2022 at Note 12. A summary of the Company's intangible assets is as follows: Balance at Amortization Foreign Currency Translation Adjustments Other (1) Balance at September 30, 2022 Intangible assets with finite lives: Gross carrying amount $ 81.8 $ — $ 0.1 $ ( 0.2 ) $ 81.7 Accumulated amortization ( 71.1 ) ( 1.8 ) — 0.2 ( 72.7 ) Total net intangible assets with finite lives $ 10.7 $ ( 1.8 ) $ 0.1 $ — $ 9.0 Intangible assets with indefinite lives: Tradename and other 300.1 — — — 300.1 Total intangible assets, net $ 310.8 $ ( 1.8 ) $ 0.1 $ — $ 309.1 (1) Amounts represent the write-off of non-compete agreements that expired during the nine months ended September 30, 2022 . The estimated aggregate future amortization expense for intangible assets is as follows: Estimated Amortization For the three months ended December 31, 2022 $ 0.6 For the twelve months ended December 31, 2023 2.5 For the twelve months ended December 31, 2024 2.5 For the twelve months ended December 31, 2025 1.9 For the twelve months ended December 31, 2026 1.5 Thereafter — Total $ 9.0

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets	9 Months Ended
	Sep. 30, 2022
Impairment or Disposal of Tangible Assets Disclosure [Abstract]
Impairment of Long-Lived Assets	12. Impairment of Long-Lived Assets The Company performed a qualitative impairment analysis on its goodwill and tradename intangible assets as of September 30, 2022. As a result of the qualitative assessment, the Company noted no impairment indicators related to its goodwill and tradename intangible assets as of September 30, 2022. The qualitative impairment analysis, by asset class, is described below: • Goodwill – The qualitative assessment of goodwill for each reporting unit considers economic and market conditions, industry trading multiples and the impact of recent developments and events on estimated fair values as compared with its most recent quantitative assessment. • Tradename Intangible Assets – The qualitative assessment considers recent developments that may impact revenue forecasts and other estimates as compared with its most recent quantitative assessment. • Other Long-lived Assets – The qualitative assessment considers relevant market transactions, industry trading multiples and recent developments that would impact the estimates of future cash flows, which are the primary measure of estimated fair value, as compared with its most recent quantitative impairment assessment. The Company performed a qualitative impairment analysis on other long-lived assets, namely theatre properties and right-of-use assets, as of September 30, 2022 to determine whether indicators of potential impairment existed at the theatre level, which is the level at which the Company tests its other long-lived assets. If an impairment indicator was identified for a theatre as a result of the qualitative test, then the Company performed a quantitative test for that theatre. The quantitative evaluation at the theatre level uses estimated undiscounted cash flows from continuing use through the remainder of the theatre’s useful life. The remainder of the theatre’s useful life correlates with the remaining lease period, which includes the probability of the exercise of available renewal periods for leased properties, and the lesser of twenty years or the building’s remaining useful life for owned properties. If the estimated undiscounted cash flows are not sufficient to recover a long-lived asset’s carrying value, the carrying value of the asset group (theatre) is compared with its estimated fair value. Significant judgment is involved in estimating fair value, including management’s estimate of future theatre level cash flows for each of the theatres based on projected box office. Fair value is estimated based on a multiple of cash flows. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy, as defined by FASB ASC Topic 820-10-35, are based on projected operating performance, market transactions and industry trading multiples. Below is a summary of impairment charges for the periods presented: Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 U.S. Segment Theatre properties $ 1.1 $ 4.8 $ 3.6 $ 4.8 Theatre operating lease right-of-use assets 2.7 2.6 4.7 2.6 Investment in NCM (1) 11.2 — 98.0 — U.S. total 15.0 7.4 106.3 7.4 International segment Theatre properties 0.1 0.1 0.8 0.1 Theatre operating lease right-of-use assets 0.1 — 0.4 — International total 0.2 0.1 1.2 0.1 Total Impairment $ 15.2 $ 7.5 $ 107.5 $ 7.5 (1) See discussion at Impairment of NCM Investment in Note 8.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	13. Fair Value Measurements The Company determines fair value measurements in accordance with ASC Topic 820, which establishes a fair value hierarchy under which an asset or liability is categorized based on the lowest level of input significant to its fair value measurement. The levels of input defined by ASC Topic 820 are as follows: Level 1 – quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date; Level 2 – other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and Level 3 – unobservable and should be used to measure fair value to the extent that observable inputs are not available. Below is a summary of assets and liabilities measured at fair value on a recurring basis under FASB ASC Topic 820 as of September 30, 2022 and December 31, 2021: Carrying Fair Value Hierarchy Description As of Value Level 1 Level 2 Level 3 Interest rate swap assets (1) September 30, 2022 $ 20.2 $ — $ 20.2 $ — Interest rate swap liabilities (1) December 31, 2021 $ 14.6 $ — $ 14.6 $ — (1) See further discussion of interest rate swaps at Note 7. The market approach is used for fair value measurements on a nonrecurring basis in the impairment evaluations of its goodwill, intangible assets and long-lived assets (see Note 11 and Note 12). See additional explanation of fair value measurement techniques used for long-lived assets, goodwill and intangible assets in “Critical Accounting Policies” in the Holdings' Annual Report on Form 10-K for the year ended December 31, 2021, filed February 25, 2022 and the CUSA's Annual Report on Form 10-K for the year ended December 31, 2021 , filed March 9, 2022. There were no changes in valuation techniques. There were no transfers into or out of Level 1, Level 2 or Level 3 during the nine months ended September 30, 2022 .

Foreign Currency Translation

Foreign Currency Translation	9 Months Ended
	Sep. 30, 2022
Foreign Currency [Abstract]
Foreign Currency Translation	14. Foreign Currency Translation The accumulated other comprehensive loss account in Holdings stockholders’ equity of $ 362.9 and $ 394.5 and CUSA stockholder's equity of $ 368.2 and $ 397.0 , each as of September 30, 2022 and December 31, 2021, respectively, primarily includes cumulative foreign currency net losses of $ 400.4 and $ 394.5 , respectively, from translating the financial statements of the Company's international subsidiaries and the cumulative changes in fair value of the interest rate swap agreements that are designated as hedges. As of September 30, 2022 , all foreign countries where the Company has operations are non-highly inflationary, other than Argentina. In non-highly inflationary countries, the local currency is the same as the functional currency and any fluctuation in the currency results in a cumulative foreign currency translation adjustment recorded to accumulated other comprehensive loss. The Company deemed Argentina to be highly inflationary beginning July 1, 2018. A highly inflationary economy is defined as an economy with a cumulative inflation rate of 100 percent or more over a three-year period. If a country’s economy is classified as highly inflationary, the financial statements of the foreign entity operating in that country must be remeasured to the functional currency of the reporting entity. The financial information of the Company’s Argentina subsidiaries was remeasured in U.S. dollars in accordance with ASC Topic 830, Foreign Currency Matters , effective July 1, 2018. Below is a summary of the impact of translating the September 30, 2022 and September 30, 2021 financial statements of the Company’s international subsidiaries: Other Comprehensive Income (Loss) for Exchange Rate as of Nine Months Ended Country September 30, 2022 December 31, 2021 September 30, 2022 September 30, 2021 Brazil 5.40 5.57 $ 0.4 $ ( 3.4 ) Chile 965.80 852.00 ( 7.7 ) ( 7.9 ) Peru 3.99 4.02 0.2 ( 3.6 ) All other 1.2 ( 0.1 ) $ ( 5.9 ) $ ( 15.0 ) As noted above, beginning July 1, 2018, Argentina was deemed highly inflationary. A foreign currency exchange loss of $ 5.1 and gain of $ 0.4 was recorded for the nine months ended September 30, 2022 and 2021 , respectively, as a result of translating Argentina's financial results to U.S. dollars.

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	9 Months Ended
	Sep. 30, 2022
Supplemental Cash Flow Elements [Abstract]
Supplemental Cash Flow Information	15. Supplemental Cash Flow Information The following is provided as supplemental information to the condensed consolidated statements of cash flows: Nine Months Ended September 30, 2022 2021 Cash paid for interest by Holdings (1) $ 121.0 $ 89.8 Cash paid for interest by CUSA $ 100.3 $ 69.5 Cash paid (refunds received) for income taxes, net $ 2.3 $ ( 136.9 ) Cash deposited in (transferred from) restricted accounts (2) $ ( 2.9 ) $ 7.3 Noncash operating activities: Interest expense - NCM (see Note 8) $ ( 17.5 ) $ ( 17.7 ) Noncash investing activities: Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment (3) $ 4.2 $ ( 2.4 ) Investment in NCM – receipt of common units (see Note 8) $ 1.3 $ 10.2 (1) Includes the cash interest paid by CUSA. (2) Represents cash deposited in a collateral account during the period to support the issuance of letters of credit to lenders, net of deposits withdrawn from such accounts upon the repayment of related debt. (3) Additions to theatre properties and equipment included in accounts payable as of September 30, 2022 and December 31, 2021 were $ 12.4 and $ 8.2 , respectively.

Segments

Segments	9 Months Ended
	Sep. 30, 2022
Segment Reporting [Abstract]
Segments	16. Segments - Holdings The international market and U.S. market are managed as separate reportable operating segments, with the international segment consisting of operations in Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay. Each segment’s revenue is derived from admissions and concession sales and other ancillary revenue. Holdings uses Adjusted EBITDA, as shown in the reconciliation table below, as the primary measure of segment profit and loss to evaluate performance and allocate its resources. The Company does not report total assets by segment because that information is not used to evaluate the performance of or allocate resources between segments. Holdings revenue, Adjusted EBITDA and capital expenditures by reportable operating segment Below is a breakdown of selected financial information by reportable operating segment for Holdings: Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 Revenue U.S. $ 514.4 $ 376.3 $ 1,491.6 $ 743.0 International 138.7 59.3 370.5 101.9 Eliminations ( 2.7 ) ( 0.8 ) ( 7.1 ) ( 1.1 ) Total revenue $ 650.4 $ 434.8 $ 1,855.0 $ 843.8 Adjusted EBITDA U.S. $ 70.7 $ 44.8 $ 196.2 $ ( 31.7 ) International 28.8 ( 0.5 ) 66.8 ( 27.8 ) Total Adjusted EBITDA $ 99.5 $ 44.3 $ 263.0 $ ( 59.5 ) Capital expenditures U.S. $ 20.2 $ 22.4 $ 50.7 $ 47.5 International 4.5 2.0 14.6 9.7 Total capital expenditures $ 24.7 $ 24.4 $ 65.3 $ 57.2 The following table sets forth a reconciliation of net loss to Adjusted EBITDA for Holdings: Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 Net loss $ ( 23.9 ) $ ( 77.6 ) $ ( 169.2 ) $ ( 428.7 ) Add (deduct): Income tax expense (benefit) 3.4 ( 8.9 ) 6.3 ( 15.6 ) Interest expense (1) 38.4 38.0 114.6 111.6 Other expense, net (2) 4.5 12.5 19.2 35.3 Cash distributions from other equity investees (3) — — 1.5 0.2 Depreciation and amortization 58.3 67.2 181.0 202.3 Impairment of long-lived and other assets 15.2 7.5 107.5 7.5 Restructuring costs — ( 0.4 ) ( 0.2 ) ( 1.3 ) (Gain) loss on disposal of assets and other 1.2 1.1 ( 6.4 ) 7.9 Loss on extinguishment of debt — — — 6.5 Non-cash rent expense ( 2.8 ) ( 1.1 ) ( 7.5 ) ( 1.8 ) Share based awards compensation expense 5.2 6.0 16.2 16.6 Adjusted EBITDA $ 99.5 $ 44.3 $ 263.0 $ ( 59.5 ) (1) Includes amortization of debt issuance costs and amortization of accumulated losses for amended swap agreements. (2) Includes interest income, foreign currency exchange (gain) loss and equity in loss of affiliates. (3) Reflects cash distributions received from equity investees that were recorded as a reduction of the respective investment balances (see Note 9). These distributions are reported entirely within the U.S. operating segment. Financial Information About Geographic Areas Below is a breakdown of selected financial information for the Company by geographic area: Three Months Ended Nine Months Ended September 30, September 30, Revenue 2022 2021 2022 2021 U.S. $ 514.4 $ 376.3 $ 1,491.6 $ 743.0 Brazil 45.2 20.6 133.1 30.5 Other international countries 93.5 38.6 237.4 71.4 Eliminations ( 2.7 ) ( 0.7 ) ( 7.1 ) ( 1.1 ) Total $ 650.4 $ 434.8 $ 1,855.0 $ 843.8 As of As of Theatre Properties and Equipment, net September 30, 2022 December 31, 2021 U.S. $ 1,105.4 $ 1,208.7 Brazil 49.6 56.8 Other international countries 105.0 117.4 Total $ 1,260.0 $ 1,382.9

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2022
Related Party Transactions [Abstract]
Related Party Transactions	17. Related Party Transactions A subsidiary of the Company manages a theatre for Laredo Theatre, Ltd. (“Laredo”). The Company is the sole general partner and owns 75 % of the limited partnership interests of Laredo. Lone Star Theatres, Inc. owns the remaining 25 % of the limited partnership interests in Laredo and is 100 % owned by Mr. David Roberts, Lee Roy Mitchell’s son-in-law. Lee Roy Mitchell, our founder and a member of Holdings' Board of Directors, owns, both directly and indirectly, approximately 8.5 % of Holdings common stock. Under the agreement, management fees are paid by Laredo to the Company at a rate of 5 % of annual theatre revenue. The Company recorded $ 0.5 and $ 0.2 of management fee revenue during the nine months ended September 30, 2022 and 2021 , respectively. All such amounts are included in each of Holdings' and CUSA's condensed consolidated financial statements with the intercompany amounts eliminated in consolidation. During the nine months ended September 30, 2022, cash distributions of $ 2.4 were paid to Lone Star Theatres, Inc. as required by the partnership agreement, which were recorded as a reduction of noncontrolling interests on the condensed consolidating balance sheet. Walter Hebert, Mr. Mitchell’s brother-in-law, previously served as the Executive Vice President – Purchasing of the Company and retired in July 2021. Mr. Hebert served as a consultant until July 2022. During the nine months ended September 30, 2022, the Company paid Mr. Hebert $ 0.2 related to consulting services. A subsidiary of the Company leases 13 theatres from Syufy Enterprises, LP (“Syufy”) or affiliates of Syufy. Raymond Syufy is one of Holdings' directors and is an officer of the general partner of Syufy. For the nine months ended September 30, 2022 and 2021, the Company paid total rent of $ 16.7 and $ 17.9 , respectively, to Syufy. CUSA provides digital equipment support to drive-in theatres owned by Syufy. The Company recorded management fees of $ 0.1 and $ 0.1 related to these services during each of the nine months ended September 30, 2022 and 2021, respectively. A subsidiary of the Company has a 50 % voting interest in FE Concepts, a joint venture with AWSR, an entity owned by Lee Roy Mitchell and Tandy Mitchell. FE Concepts operates a family entertainment center that offers bowling, gaming, movies and other amenities. See Note 9 for further discussion. CUSA has a theatre services agreement with FE Concepts under which the Company receives service fees for providing film booking and equipment monitoring services for the facility. CUSA has paid certain fees on behalf of its parent, Holdings, and Holdings has paid income taxes and other expenses on behalf of CUSA. The net receivable from Holdings as of September 30, 2022 and December 31, 2021 was $ 60.5 and $ 46.7 , respectively. CUSA received contributions from Holdings of $ 120.0 during the nine months ended September 30, 2021.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	18. Commitments and Contingencies From time to time, the Company is involved in various legal proceedings arising from the ordinary course of its business operations, such as personal injury claims, employment matters, patent claims, landlord-tenant disputes, contractual disputes with landlords over certain termination rights or the right to discontinue rent payments due to the COVID-19 pandemic and other contractual disputes, some of which are covered by insurance. The Company believes its potential liability with respect to proceedings currently pending is not material, individually or in the aggregate, to the Company’s financial position, results of operations and cash flows. Cinemark Holdings, Inc., et al vs Factory Mutual Insurance Company . The Company filed suit on November 18, 2020, in the District Court, 471st Judicial District, Collin County, Texas. On December 22, 2020, the case was moved to the US District Court for the Eastern District of Texas, Sherman Division. The Company submitted a claim under its property insurance policy issued by Factory Mutual Insurance Company (the “FM Policy”) for losses sustained as a result of the closure of the Company’s theatres due to the COVID-19 pandemic. Factory Mutual Insurance Company (“FM”) denied the Company’s claim. The Company is seeking damages resulting from FM’s breach of contract, FM’s bad faith conduct and a declaration of the parties’ rights under the FM Policy. The Company cannot predict the outcome of this litigation. Lakeenya Neal, et al v. Cinemark Holdings, Inc., et al. This class action lawsuit was filed against the Company on December 10, 2021, in the Central District of Los Angeles County Superior Court of the State of California alleging certain violations of the Fair and Accurate Credit Transactions Act. We firmly maintain that the allegations are without merit and will vigorously defend this lawsuit. The Company cannot predict the outcome of this litigation.

Lease Accounting (Tables)

Lease Accounting (Tables)	9 Months Ended
	Sep. 30, 2022
Leases [Abstract]
Schedule of Aggregate Lease Costs by Lease Classification	The following table represents the Company’s aggregate lease costs, by lease classification, for the periods presented. Three Months Ended Nine Months Ended September 30, September 30, Lease Cost Classification 2022 2021 2022 2021 Operating lease costs Equipment (1) Utilities and other $ 1.0 $ 0.7 $ 2.6 $ 1.6 Real Estate (2)(3) Facility lease expense 79.5 69.5 236.4 200.9 Total operating lease costs $ 80.5 $ 70.2 $ 239.0 $ 202.5 Finance lease costs Amortization of leased assets Depreciation and amortization $ 3.1 $ 3.1 $ 9.4 $ 9.5 Interest on lease liabilities Interest expense 1.4 1.4 4.1 4.5 Total finance lease costs $ 4.5 $ 4.5 $ 13.5 $ 14.0 (1) Includes approximately $ 0.8 and $ 0.6 of short-term lease payments for the three months ended September 30, 2022 and 2021, respectively. Includes approximately $ 2.2 and $ 1.2 of short-term lease payments for the nine months ended September 30, 2022 and 2021 , respectively. (2) Includes approximately $ 9.4 and $ 1.9 of variable lease payments based on a change in index, such as CPI or inflation, variable payments based on revenue or attendance and variable common area maintenance costs for the three months ended September 30, 2022 and 2021, respectively. Includes approximately $ 27.5 and $ ( 0.1 ) of variable lease payments based on a change in index, such as CPI or inflation, variable payments based on revenue or attendance and variable common area maintenance costs for the nine months ended September 30, 2022 and 2021 , respectively. (3) Approximately $ 0.3 and $ 0.3 of lease payments are included in general and administrative expense prim arily related to office leases for the three months ended September 30, 2022 and 2021, respectively. Approximately $ 1.0 and $ 1.0 of lease payments are included in general and administrative expense prim arily related to office leases for the nine months ended September 30, 2022 and 2021 , respectively.
Schedule of Minimum Cash Lease Payments	The following table represents the minimum cash lease payments included in the measurement of lease liabilities and the non-cash addition of lease right-of-use assets for the periods presented. Nine Months Ended September 30, Other Information 2022 2021 Cash paid for amounts included in the measurement of lease liabilities Cash outflows for operating leases $ 209.3 $ 201.4 Cash outflows for finance leases - operating activities $ 4.1 $ 4.5 Cash outflows for finance leases - financing activities $ 10.8 $ 11.0 Non-cash amount of right-of-use assets obtained in exchange for: Operating lease liability additions, net of write-offs $ 78.5 $ 109.1

Revenue Recognition (Tables)

Revenue Recognition (Tables)	9 Months Ended
	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Summary of Revenues Disaggregated Based on Type of Good or Service by Reportable Operating Segment and on Timing of Revenue Recognition	The following tables present revenue disaggregated based on major type of good or service and by reportable operating segment. Three Months Ended Nine Months Ended September 30, 2022 September 30, 2022 U.S. International U.S. International Operating Operating Operating Operating Segment (1) Segment Consolidated Segment (1) Segment Consolidated Admissions revenue $ 257.6 $ 67.0 $ 324.6 $ 759.1 $ 183.2 $ 942.3 Concession revenue 200.8 52.8 253.6 576.5 136.1 712.6 Screen advertising, screen rental and promotional revenue (2) 20.6 11.3 31.9 60.7 30.7 91.4 Other revenue 32.7 7.6 40.3 88.2 20.5 108.7 Total revenue $ 511.7 $ 138.7 $ 650.4 $ 1,484.5 $ 370.5 $ 1,855.0 Three Months Ended Nine Months Ended September 30, 2021 September 30, 2021 U.S. International U.S. International Operating Operating Operating Operating Segment (1) Segment Consolidated Segment (1) Segment Consolidated Admissions revenue $ 195.3 $ 30.2 $ 225.5 $ 384.4 $ 50.7 $ 435.1 Concession revenue 142.6 21.6 164.2 275.0 38.5 313.5 Screen advertising, screen rental and promotional revenue (2) 18.0 4.8 22.8 44.5 7.6 52.1 Other revenue 19.5 2.8 22.3 37.9 5.2 43.1 Total revenue $ 375.4 $ 59.4 $ 434.8 $ 741.8 $ 102.0 $ 843.8 (1) U.S. segment revenue excludes intercompany transactions with the international operating segment. See Note 16 for the amount of intercompany eliminations for the periods presented. (2) Amount includes amortization of NCM screen advertising advances. See NCM Screen Advertising Advances and Other Deferred Revenue below . The following tables present revenue disaggregated based on timing of recognition and by reportable operating segment. Three Months Ended Nine Months Ended September 30, 2022 September 30, 2022 U.S. International U.S. International Operating Operating Operating Operating Segment (1) Segment Consolidated Segment (1) Segment Consolidated Goods and services transferred at a point in time $ 478.9 $ 123.8 $ 602.7 $ 1,401.0 $ 332.2 $ 1,733.2 Goods and services transferred over time (2) 32.8 14.9 47.7 83.5 38.3 121.8 Total $ 511.7 $ 138.7 $ 650.4 $ 1,484.5 $ 370.5 $ 1,855.0 Three Months Ended Nine Months Ended September 30, 2021 September 30, 2021 U.S. International U.S. International Operating Operating Operating Operating Segment (1) Segment Consolidated Segment (1) Segment Consolidated Goods and services transferred at a point in time $ 348.4 $ 53.3 $ 401.7 $ 678.4 $ 91.5 $ 769.9 Goods and services transferred over time (2) 27.0 6.1 33.1 63.4 10.5 73.9 Total $ 375.4 $ 59.4 $ 434.8 $ 741.8 $ 102.0 $ 843.8 (1) U.S. segment revenue excludes intercompany transactions with the international operating segment. See Note 16 for the amount of intercompany eliminations for the periods presented. Amount includes amortization of NCM screen advertising advances. See NCM Screen Advertising Advances and Other Deferred Revenue below.
Changes in Advances and Deferred Revenues	The following table presents changes in the Company’s NCM screen advertising advances and other deferred revenue for the nine months ended September 30, 2022. NCM screen advertising advances (1) Other (2) Balance at January 1, 2022 $ 346.0 $ 160.3 Amounts recognized as accounts receivable — 1.0 Cash received from customers in advance — 163.5 Common units received from NCM 1.3 — Interest accrued related to significant financing component 17.5 — Revenue recognized during period ( 24.3 ) ( 150.9 ) Foreign currency translation adjustments — ( 1.0 ) Balance at September 30, 2022 $ 340.5 $ 172.9 (1) See Note 8 for the maturity of NCM screen advertising advances as of September 30, 2022 . (2) Includes liabilities associated with outstanding gift cards and discount ticket vouchers, points or rebates outstanding under the Company’s loyalty and membership programs and revenue collected but not yet earned for screen advertising, screen rental and other promotional activities. Amounts are classified as accounts payable and accrued expenses or other long-term liabilities on the condensed consolidated balance sheet.
Aggregate Amount of Transaction Price Allocated to Performance Obligationt that are Unsatisfied and Expected to be Recognized	The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied as of September 30, 2022 and when the Company expects to recognize this revenue. Twelve Months Ended September 30, Remaining Performance Obligations 2023 2024 Thereafter Total Other deferred revenue $ 153.3 $ 19.6 $ — $ 172.9

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Schedule of computations of basic and diluted loss per share	The following table presents computations of basic and diluted loss per share for Holdings: Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 Numerator: Net loss attributable to Cinemark Holdings, Inc. $ ( 24.5 ) $ ( 77.8 ) $ ( 171.9 ) $ ( 428.5 ) Loss allocated to participating share-based awards (1) 0.4 1.5 2.4 7.6 Net loss attributable to common stockholders $ ( 24.1 ) $ ( 76.3 ) $ ( 169.5 ) $ ( 420.9 ) Denominator : Basic weighted average shares outstanding 118.4 117.3 118.1 117.2 Common equivalent shares for restricted stock units (2) — — — — Common equivalent shares for convertible notes and warrants (3) — — — — Diluted weighted average shares outstanding 118.4 117.3 118.1 117.2 Basic loss per share attributable to common stockholders $ ( 0.20 ) $ ( 0.65 ) $ ( 1.43 ) $ ( 3.59 ) Diluted loss per share attributable to common stockholders $ ( 0.20 ) $ ( 0.65 ) $ ( 1.43 ) $ ( 3.59 ) (1) For the three months ended September 30, 2022 and 2021, a weighted average of approximately 1.90 shares and 2.34 shares of restricted stock, respectively, were considered participating securities. For the nine months ended September 30, 2022 and 2021, a weighted average of approximately 1.69 shares and 2.11 shares of restricted stock, respectively, were considered participating securities. (2) For the three months ended September 30, 2022 and 2021 , approximately 0.18 and 0.10 common equivalent shares for restricted stock units, respectively, were excluded because they were anti-dilutive. For the nine months ended September 30, 2022 and 2021 , approximately 0.39 and 0.10 common equivalent shares for restricted stock units, respectively, were excluded because they were anti-dilutive. (3) For the three and nine months ended September 30, 2022 and 2021, diluted loss per share excludes the conversion of the 4.50 % Convertible Senior Notes into 32.0 shares of common stock, as well as outstanding warrants, as they would be anti-dilutive. See further discussion below.

Long Term Debt (Tables)

Long Term Debt (Tables)	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Components of Long-Term Debt	Long-term debt of Holdings consisted of the following for the periods presented: September 30, December 31, 2022 2021 Cinemark Holdings, Inc. 4.500% convertible senior notes due 2025 $ 460.0 $ 460.0 Cinemark USA, Inc. term loan due 2025 628.2 633.1 Cinemark USA, Inc. 8.750% senior secured notes due 2025 250.0 250.0 Cinemark USA, Inc. 5.875% senior notes due 2026 405.0 405.0 Cinemark USA, Inc. 5.250% senior notes due 2028 765.0 765.0 Other 21.9 30.2 Total carrying value of long-term debt $ 2,530.1 $ 2,543.3 Less: Current portion 22.0 24.3 Less: Debt issuance costs, net of accumulated amortization 34.6 42.7 Long-term debt, less current portion, net of unamortized debt issuance costs $ 2,473.5 $ 2,476.3 Long-term debt of CUSA consisted of the following for the periods presented: September 30, December 31, 2022 2021 Cinemark USA, Inc. term loan due 2025 $ 628.2 $ 633.1 Cinemark USA, Inc. 8.750% senior secured notes due 2025 250.0 250.0 Cinemark USA, Inc. 5.875% senior notes due 2026 405.0 405.0 Cinemark USA, Inc. 5.250% senior notes due 2028 765.0 765.0 Other 21.9 30.2 Total carrying value of long-term debt $ 2,070.1 $ 2,083.3 Less: Current portion 22.0 24.3 Less: Debt issuance costs, net of accumulated amortization 24.7 30.3 Long-term debt, less current portion, net of unamortized debt issuance costs $ 2,023.4 $ 2,028.7
Summary of Company's Interest Rate Swap Agreements Designated as Cash Flow Hedges	Below is a summary of the Company's interest rate swap agreements, which are designated as cash flow hedges, as of September 30, 2022: Notional Estimated Amount Effective Date Pay Rate Receive Rate Expiration Date Fair Value (1) $ 137.5 December 31, 2018 2.12 % 1-Month LIBOR December 31, 2024 $ 6.1 $ 175.0 December 31, 2018 2.12 % 1-Month LIBOR December 31, 2024 8.0 $ 137.5 December 31, 2018 2.19 % 1-Month LIBOR December 31, 2024 6.1 Total $ 20.2 (1) Approximately $ 9.9 of the total is included in prepaid expenses and other and $ 10.3 is included in deferred charges and other assets, net on the condensed consolidated balance sheet as of September 30, 2022 .
Schedule of carrying values and fair values of debt instruments	The table below presents the fair value of the Company's long-term debt as of the periods presented: As of September 30, 2022 December 31, 2021 Holdings fair value (1) $ 2,326.2 $ 2,749.8 CUSA fair value $ 1,798.7 $ 2,058.0 (1) Includes the fair value of the 4.500 % convertible senior notes of $ 527.5 and $ 691.9 as of September 30, 2022 and December 31, 2021, respectively.

Investment in National CineMe_2

Investment in National CineMedia LLC (Tables)	9 Months Ended
	Sep. 30, 2022
Aggregate Amount of Transaction Price Allocated to Performance Obligationt that are Unsatisfied and Expected to be Recognized	The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied as of September 30, 2022 and when the Company expects to recognize this revenue. Twelve Months Ended September 30, Remaining Performance Obligations 2023 2024 Thereafter Total Other deferred revenue $ 153.3 $ 19.6 $ — $ 172.9
Summary Financial Information	Below is summary financial information for NCM for the periods indicated: Three Months Ended Three Months Ended Nine Months Ended Nine Months Ended September 29, 2022 September 30, 2021 September 29, 2022 September 30, 2021 Gross revenue $ 54.5 $ 31.7 $ 157.5 $ 51.1 Operating loss $ ( 4.3 ) $ ( 18.7 ) $ ( 21.2 ) $ ( 76.6 ) Net loss $ ( 24.4 ) $ ( 35.3 ) $ ( 79.0 ) $ ( 125.7 ) As of As of September 29, 2022 December 30, 2021 Current assets $ 123.5 $ 115.4 Noncurrent assets $ 637.5 $ 658.0 Current liabilities $ 72.7 $ 67.2 Noncurrent liabilities $ 1,162.4 $ 1,114.7 Members deficit $ ( 474.1 ) $ ( 408.5 )
N C M Screen Advertising Advances
Aggregate Amount of Transaction Price Allocated to Performance Obligationt that are Unsatisfied and Expected to be Recognized	The deferred NCM screen advertising advances are recorded on a straight-line basis over the term of the amended ESA through February 2041. The table below summarizes when the Company expects to recognize this revenue: Twelve Months Ended September 30, Remaining Maturity 2023 2024 2025 2026 2027 Thereafter Total NCM screen advertising advances (1) $ 9.6 $ 10.3 $ 11.0 $ 11.8 $ 12.6 $ 285.2 $ 340.5
NCM
Summary of Activity With Equity Investee Included in the Company's Condensed Consolidated Financial Statements	Below is a summary of activity with NCM included in each of Holdings' and CUSA's condensed consolidated financial statements: Investment NCM Screen Advertising Advances Equity in Other Interest Cash (2) Balance as of January 1, 2022 $ 135.4 $ ( 346.0 ) Receipt of common units due to annual common unit adjustment ("CUA") 1.3 ( 1.3 ) Screen rental revenue earned under ESA (1) — — $ — $ ( 15.0 ) $ — $ 15.0 Interest accrued related to significant financing component — ( 17.5 ) — — 17.5 — Equity in loss ( 10.3 ) — 10.3 — — — Impairment of investment in NCM ( 98.0 ) — — — — — Amortization of screen advertising advances — 24.3 — ( 24.3 ) — — Balance as of and for the nine months ended September 30, 2022 $ 28.4 $ ( 340.5 ) $ 10.3 $ ( 39.3 ) $ 17.5 $ 15.0 (1) Amounts include the per patron and per digital screen theatre access fees due to CUSA, net of amounts due to NCM for on-screen advertising time provided to the Company's beverage concessionaire of approximately $ 5.9 . (2) The Company had a receivable from NCM of $ 5.1 as of September 30, 2022 .

Other Investments (Tables)

Other Investments (Tables)	9 Months Ended
	Sep. 30, 2022
Summary Financial Information	Below is summary financial information for NCM for the periods indicated: Three Months Ended Three Months Ended Nine Months Ended Nine Months Ended September 29, 2022 September 30, 2021 September 29, 2022 September 30, 2021 Gross revenue $ 54.5 $ 31.7 $ 157.5 $ 51.1 Operating loss $ ( 4.3 ) $ ( 18.7 ) $ ( 21.2 ) $ ( 76.6 ) Net loss $ ( 24.4 ) $ ( 35.3 ) $ ( 79.0 ) $ ( 125.7 ) As of As of September 29, 2022 December 30, 2021 Current assets $ 123.5 $ 115.4 Noncurrent assets $ 637.5 $ 658.0 Current liabilities $ 72.7 $ 67.2 Noncurrent liabilities $ 1,162.4 $ 1,114.7 Members deficit $ ( 474.1 ) $ ( 408.5 )
Summary Of distributions and warranty reimbursements from DCIP Table [Text Block]	The Company received distributions and warranty reimbursements from DCIP for the three and nine months ended September 30, 2022 and 2021 as follows: Three Months Ended Nine Months Ended Transactions September 30, 2022 September 30, 2021 September 30, 2022 September 30, 2021 Warranty reimbursements (1) $ — $ ( 0.1 ) $ — $ ( 0.8 ) Distributions from DCIP (2) $ 3.7 $ 6.5 $ 3.7 $ 6.5 (1) Recorded as a reduction of utilities and other costs on the condensed consolidated statements of loss. (2) Cash distributions received from DCIP are not treated as a reduction of the investment balance because, as discussed above, the Company's equity investment in DCIP is zero. Reflected as distributions from DCIP on the condensed consolidated statements of loss.
Summary of Activity for Each of Company's Other Investments	Below is a summary of transactions with each of the Company’s other investees for the three and nine months ended September 30, 2022 and 2021: Three Months Ended Nine Months Ended Investee Transactions September 30, 2022 September 30, 2021 September 30, 2022 September 30, 2021 AC JV, LLC Event fees paid (1) $ 2.1 $ 0.8 $ 6.6 $ 1.4 DCDC Content delivery fees paid (1) $ 0.1 $ 0.2 $ 0.4 $ 0.4 (1) Included in film rentals and advertising costs on the condensed consolidated statements of loss.
Digital Cinema Implementation Partners
Transactions with DCIP	Below is a summary of activity for each of the Company’s other investees and corresponding changes to the Company's investment balances during the nine months ended September 30, 2022: AC JV, DCDC FE Concepts Other Total Balance at January 1, 2022 $ 3.7 $ 1.8 $ 19.3 $ 0.4 $ 25.2 Cash distributions received ( 1.5 ) — — — ( 1.5 ) Equity income 1.6 0.1 1.1 — 2.8 Other — — — ( 0.2 ) ( 0.2 ) Balance at September 30, 2022 $ 3.8 $ 1.9 $ 20.4 $ 0.2 $ 26.3

Treasury Stock and Share Base_2

Treasury Stock and Share Based Awards (Tables)	9 Months Ended
	Sep. 30, 2022
Summary of Treasury Stock Activity	Below is a summary of treasury stock activity for the nine months ended September 30, 2022: Number of Treasury Shares Cost Balance at January 1, 2022 5.35 $ 91.1 Restricted stock withholdings (1) 0.24 4.1 Restricted stock forfeitures 0.07 — Balance at September 30, 2022 5.66 $ 95.2 (1) Holdings withheld shares as a result of the election by certain employees to satisfy their tax liabilities upon vesting of restricted stock and restricted stock units. Holdings determined the number of shares to be withheld based upon market values of the common stock of Holdings on the vest dates, which ranged from $ 15.18 to $ 18.33 per share.
Summary of Restricted Stock Activity	Below is a summary of restricted stock activity for the nine months ended September 30, 2022: Shares of Weighted Restricted Grant Date Stock Fair Value Outstanding at January 1, 2022 2.00 $ 21.73 Granted 0.88 $ 16.40 Vested ( 0.90 ) $ 19.00 Forfeited ( 0.07 ) $ 18.80 Outstanding at September 30, 2022 1.91 $ 20.66 Unvested restricted stock at September 30, 2022 1.91 $ 20.66
CUSA
Summary of Restricted Stock and Restricted Stock Unit Award Activity	Nine Months Ended 2022 2021 Compensation expense recognized during the period CUSA employees $ 11.3 $ 13.1 Holdings directors 0.7 0.7 Total recognized by Holdings $ 12.0 $ 13.8 Fair value of vested restricted stock held by: CUSA employees $ 14.6 $ 1.2 Holdings directors 0.6 1.3 Holdings total $ 15.2 $ 2.5 Income tax benefit (cost) related to vested restricted stock held by: CUSA employees $ 2.4 $ ( 0.4 ) Holdings directors 0.1 0.3 Holdings total income tax benefit (cost) $ 2.5 $ ( 0.1 )
Restricted Stock
Summary of Restricted Stock and Restricted Stock Unit Award Activity	As of September 30, 2022, the estimated remaining unrecognized compensation expense related to unvested restricted stock awards was as follows: Estimated Remaining Expense CUSA employees (1) $ 23.0 Holdings directors 0.8 Total remaining - Holdings (1) $ 23.8
Restricted Stock Units (RSUs)
Summary of Restricted Stock and Restricted Stock Unit Award Activity	Below is a summary of restricted stock unit activity for the periods presented: Nine Months Ended September 30, 2022 2021 Number of restricted stock units that vested during the period 0.10 0.01 Fair value of restricted stock units that vested during the period $ 1.7 $ 0.3 Accumulated dividends paid upon vesting of restricted stock units $ 0.3 $ 0.1 Compensation expense recognized during the period $ 4.2 $ 2.8 Income tax benefit (cost) related to restricted stock units $ 0.1 $ ( 0.5 )

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Goodwill	A summary of the Company's goodwill is as follows: U.S. International Total Balance at January 1, 2022 (1) $ 1,182.9 $ 65.9 $ 1,248.8 Foreign currency translation adjustments — 0.4 0.4 Balance at September 30, 2022 (1) $ 1,182.9 $ 66.3 $ 1,249.2 (1) Balances are presented net of accumulated impairment losses of $ 214.0 for the U.S. operating segment and $ 43.8 for the international operating segment. See discussion of the qualitative impairment analysis performed by the Company as of September 30, 2022 at Note 12.
Intangible Assets	A summary of the Company's intangible assets is as follows: Balance at Amortization Foreign Currency Translation Adjustments Other (1) Balance at September 30, 2022 Intangible assets with finite lives: Gross carrying amount $ 81.8 $ — $ 0.1 $ ( 0.2 ) $ 81.7 Accumulated amortization ( 71.1 ) ( 1.8 ) — 0.2 ( 72.7 ) Total net intangible assets with finite lives $ 10.7 $ ( 1.8 ) $ 0.1 $ — $ 9.0 Intangible assets with indefinite lives: Tradename and other 300.1 — — — 300.1 Total intangible assets, net $ 310.8 $ ( 1.8 ) $ 0.1 $ — $ 309.1 (1) Amounts represent the write-off of non-compete agreements that expired during the nine months ended September 30, 2022 .
Estimated Aggregate Future Amortization Expense for Intangible Assets	The estimated aggregate future amortization expense for intangible assets is as follows: Estimated Amortization For the three months ended December 31, 2022 $ 0.6 For the twelve months ended December 31, 2023 2.5 For the twelve months ended December 31, 2024 2.5 For the twelve months ended December 31, 2025 1.9 For the twelve months ended December 31, 2026 1.5 Thereafter — Total $ 9.0

Impairment of Long-Lived Asse_2

Impairment of Long-Lived Assets (Tables)	9 Months Ended
	Sep. 30, 2022
Impairment or Disposal of Tangible Assets Disclosure [Abstract]
Summary of Impairment Charges	is a summary of impairment charges for the periods presented: Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 U.S. Segment Theatre properties $ 1.1 $ 4.8 $ 3.6 $ 4.8 Theatre operating lease right-of-use assets 2.7 2.6 4.7 2.6 Investment in NCM (1) 11.2 — 98.0 — U.S. total 15.0 7.4 106.3 7.4 International segment Theatre properties 0.1 0.1 0.8 0.1 Theatre operating lease right-of-use assets 0.1 — 0.4 — International total 0.2 0.1 1.2 0.1 Total Impairment $ 15.2 $ 7.5 $ 107.5 $ 7.5 (1) See discussion at Impairment of NCM Investment in Note 8.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Measured On Recurring Basis	Below is a summary of assets and liabilities measured at fair value on a recurring basis under FASB ASC Topic 820 as of September 30, 2022 and December 31, 2021: Carrying Fair Value Hierarchy Description As of Value Level 1 Level 2 Level 3 Interest rate swap assets (1) September 30, 2022 $ 20.2 $ — $ 20.2 $ — Interest rate swap liabilities (1) December 31, 2021 $ 14.6 $ — $ 14.6 $ — (1) See further discussion of interest rate swaps at Note 7.

Foreign Currency Translation (T

Foreign Currency Translation (Tables)	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Summary of Impact of Translating Financial Statements of Company's International Subsidiaries	Below is a summary of the impact of translating the September 30, 2022 and September 30, 2021 financial statements of the Company’s international subsidiaries: Other Comprehensive Income (Loss) for Exchange Rate as of Nine Months Ended Country September 30, 2022 December 31, 2021 September 30, 2022 September 30, 2021 Brazil 5.40 5.57 $ 0.4 $ ( 3.4 ) Chile 965.80 852.00 ( 7.7 ) ( 7.9 ) Peru 3.99 4.02 0.2 ( 3.6 ) All other 1.2 ( 0.1 ) $ ( 5.9 ) $ ( 15.0 ) As noted above, beginning July 1, 2018, Argentina was deemed highly inflationary. A foreign currency exchange loss of $ 5.1 and gain of $ 0.4 was recorded for the nine months ended September 30, 2022 and 2021 , respectively, as a result of translating Argentina's financial results to U.S. dollars.

Supplemental Cash Flow Inform_2

Supplemental Cash Flow Information (Tables)	9 Months Ended
	Sep. 30, 2022
Supplemental Cash Flow Elements [Abstract]
Supplemental Information to Condensed Consolidated Statements of Cash Flows	The following is provided as supplemental information to the condensed consolidated statements of cash flows: Nine Months Ended September 30, 2022 2021 Cash paid for interest by Holdings (1) $ 121.0 $ 89.8 Cash paid for interest by CUSA $ 100.3 $ 69.5 Cash paid (refunds received) for income taxes, net $ 2.3 $ ( 136.9 ) Cash deposited in (transferred from) restricted accounts (2) $ ( 2.9 ) $ 7.3 Noncash operating activities: Interest expense - NCM (see Note 8) $ ( 17.5 ) $ ( 17.7 ) Noncash investing activities: Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment (3) $ 4.2 $ ( 2.4 ) Investment in NCM – receipt of common units (see Note 8) $ 1.3 $ 10.2 (1) Includes the cash interest paid by CUSA. (2) Represents cash deposited in a collateral account during the period to support the issuance of letters of credit to lenders, net of deposits withdrawn from such accounts upon the repayment of related debt. (3) Additions to theatre properties and equipment included in accounts payable as of September 30, 2022 and December 31, 2021 were $ 12.4 and $ 8.2 , respectively.

Segments (Tables)

Segments (Tables)	9 Months Ended
	Sep. 30, 2022
Segment Reporting [Abstract]
Selected Financial Information by Reportable Operating Segment	Below is a breakdown of selected financial information by reportable operating segment for Holdings: Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 Revenue U.S. $ 514.4 $ 376.3 $ 1,491.6 $ 743.0 International 138.7 59.3 370.5 101.9 Eliminations ( 2.7 ) ( 0.8 ) ( 7.1 ) ( 1.1 ) Total revenue $ 650.4 $ 434.8 $ 1,855.0 $ 843.8 Adjusted EBITDA U.S. $ 70.7 $ 44.8 $ 196.2 $ ( 31.7 ) International 28.8 ( 0.5 ) 66.8 ( 27.8 ) Total Adjusted EBITDA $ 99.5 $ 44.3 $ 263.0 $ ( 59.5 ) Capital expenditures U.S. $ 20.2 $ 22.4 $ 50.7 $ 47.5 International 4.5 2.0 14.6 9.7 Total capital expenditures $ 24.7 $ 24.4 $ 65.3 $ 57.2
Reconciliation of Net Income (Loss) to Adjusted EBITDA	The following table sets forth a reconciliation of net loss to Adjusted EBITDA for Holdings: Three Months Ended Nine Months Ended September 30, September 30, 2022 2021 2022 2021 Net loss $ ( 23.9 ) $ ( 77.6 ) $ ( 169.2 ) $ ( 428.7 ) Add (deduct): Income tax expense (benefit) 3.4 ( 8.9 ) 6.3 ( 15.6 ) Interest expense (1) 38.4 38.0 114.6 111.6 Other expense, net (2) 4.5 12.5 19.2 35.3 Cash distributions from other equity investees (3) — — 1.5 0.2 Depreciation and amortization 58.3 67.2 181.0 202.3 Impairment of long-lived and other assets 15.2 7.5 107.5 7.5 Restructuring costs — ( 0.4 ) ( 0.2 ) ( 1.3 ) (Gain) loss on disposal of assets and other 1.2 1.1 ( 6.4 ) 7.9 Loss on extinguishment of debt — — — 6.5 Non-cash rent expense ( 2.8 ) ( 1.1 ) ( 7.5 ) ( 1.8 ) Share based awards compensation expense 5.2 6.0 16.2 16.6 Adjusted EBITDA $ 99.5 $ 44.3 $ 263.0 $ ( 59.5 ) (1) Includes amortization of debt issuance costs and amortization of accumulated losses for amended swap agreements. (2) Includes interest income, foreign currency exchange (gain) loss and equity in loss of affiliates. (3) Reflects cash distributions received from equity investees that were recorded as a reduction of the respective investment balances (see Note 9). These distributions are reported entirely within the U.S. operating segment.
Selected Financial Information by Geographic Area	Below is a breakdown of selected financial information for the Company by geographic area: Three Months Ended Nine Months Ended September 30, September 30, Revenue 2022 2021 2022 2021 U.S. $ 514.4 $ 376.3 $ 1,491.6 $ 743.0 Brazil 45.2 20.6 133.1 30.5 Other international countries 93.5 38.6 237.4 71.4 Eliminations ( 2.7 ) ( 0.7 ) ( 7.1 ) ( 1.1 ) Total $ 650.4 $ 434.8 $ 1,855.0 $ 843.8 As of As of Theatre Properties and Equipment, net September 30, 2022 December 31, 2021 U.S. $ 1,105.4 $ 1,208.7 Brazil 49.6 56.8 Other international countries 105.0 117.4 Total $ 1,260.0 $ 1,382.9

The Company and Basis of Pres_2

The Company and Basis of Presentation - Additional Information (Detail)	Sep. 30, 2022
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Operating revenues comprise	100%
Operating expenses comprise	100%
Minimum | Equity Interest Member
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Equity method investment, ownership percentage	20%
Maximum
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Cost method investment, ownership Percentage	20%
Maximum | Equity Interest Member
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Equity method investment, ownership percentage	50%

Impact of COVID-19 Pandemic - A

Impact of COVID-19 Pandemic - Additional Information (Detail) - Impact of COVID-19 Pandemic $ in Millions	9 Months Ended
	Sep. 30, 2022 USD ($)
Unusual Or Infrequent Item [Line Items]
Accrued restructuring costs	$ 0.4
Restructuring costs	0.9
Reduction In Accrued Restructuring Costs	0.2
Remaining accrued restructuring costs	$ 0.4

Lease Accounting - Additional I

Lease Accounting - Additional Information (Detail) - Theatres - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Lease [Line Items]
Lease payments withheld or deferred	$ 5.3	$ 31.9
Contractual minimum lease payments payable under operating lease, lease not yet commenced	$ 69.3

Schedule of Aggregate Lease Cos

Schedule of Aggregate Lease Costs by Lease Classification (Detail) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating lease costs
Total operating lease costs		$ 80.5	$ 70.2	$ 239	$ 202.5
Finance lease costs
Total finance lease costs		4.5	4.5	13.5	14
Depreciation and Amortization
Finance lease costs
Amortization of leased assets		3.1	3.1	9.4	9.5
Interest Expense
Finance lease costs
Interest on lease liabilities		1.4	1.4	4.1	4.5
Equipment | Utilities and Other
Operating lease costs
Total operating lease costs	[1]	1	0.7	2.6	1.6
Real Estate | Facility Lease Expense
Operating lease costs
Total operating lease costs	[2],[3]	$ 79.5	$ 69.5	$ 236.4	$ 200.9
[1] Includes approximately $ 0.8 and $ 0.6 of short-term lease payments for the three months ended September 30, 2022 and 2021, respectively. Includes approximately $ 2.2 and $ 1.2 of short-term lease payments for the nine months ended September 30, 2022 and 2021 , respectively. Approximately $ 0.3 and $ 0.3 of lease payments are included in general and administrative expense prim arily related to office leases for the three months ended September 30, 2022 and 2021, respectively. Approximately $ 1.0 and $ 1.0 of lease payments are included in general and administrative expense prim arily related to office leases for the nine months ended September 30, 2022 and 2021 , respectively. Includes approximately $ 9.4 and $ 1.9 of variable lease payments based on a change in index, such as CPI or inflation, variable payments based on revenue or attendance and variable common area maintenance costs for the three months ended September 30, 2022 and 2021, respectively. Includes approximately $ 27.5 and $ ( 0.1 ) of variable lease payments based on a change in index, such as CPI or inflation, variable payments based on revenue or attendance and variable common area maintenance costs for the nine months ended September 30, 2022 and 2021 , respectively.

Schedule of Aggregate Lease C_2

Schedule of Aggregate Lease Costs by Lease Classification (Parenthetical) (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Lease Cost [Line Items]
Lease payments			$ 209.3	$ 201.4
Equipment | Utilities and Other
Lease Cost [Line Items]
Short term lease payments	$ 0.8	$ 0.6	2.2	1.2
Real Estate | Facility Lease Expense
Lease Cost [Line Items]
Variable lease payments	9.4	1.9	27.5	(0.1)
Lease payments	$ 0.3	$ 0.3	$ 1	$ 1

Schedule of Minimum Cash Lease

Schedule of Minimum Cash Lease Payments (Detail) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Contractual cash payments included in the measurement of lease liabilities
Cash outflows for operating leases	$ 209.3	$ 201.4
Cash outflows for finance leases - operating activities	4.1	4.5
Cash outflows for finance leases - financing activities	10.8	11
Non-cash amount of leased assets obtained in exchange for:
Operating lease liability additions, net of write-offs	$ 78.5	$ 109.1

Revenue Recognition - Additiona

Revenue Recognition - Additional Information (Detail) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Receivables related to contracts with customers	$ 19,400,000	$ 23,500,000
Assets related to costs to obtain or fulfill contract with customers	$ 0

Revenue Recognition - Summary o

Revenue Recognition - Summary of Revenues Disaggregated Based on Major Type of Good or Service and by Reportable Operating Segment (Detail) - USD ($) $ in Millions		3 Months Ended				9 Months Ended
		Sep. 30, 2022		Sep. 30, 2021		Sep. 30, 2022		Sep. 30, 2021
Disaggregation of Revenue [Line Items]
Total revenue		$ 650.4		$ 434.8		$ 1,855		$ 843.8
Admissions Revenues
Disaggregation of Revenue [Line Items]
Total revenue		324.6		225.5		942.3		435.1
Concession Revenues
Disaggregation of Revenue [Line Items]
Total revenue		253.6		164.2		712.6		313.5
Screen Advertising, Screen Rental and Promotional Revenues
Disaggregation of Revenue [Line Items]
Total revenue	[1]	31.9		22.8		91.4		52.1
Other Revenues
Disaggregation of Revenue [Line Items]
Total revenue		40.3		22.3		108.7		43.1
U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenue	[2]	511.7		375.4		1,484.5		741.8
U.S. Operating Segment | Admissions Revenues
Disaggregation of Revenue [Line Items]
Total revenue	[2]	257.6		195.3		759.1		384.4
U.S. Operating Segment | Concession Revenues
Disaggregation of Revenue [Line Items]
Total revenue	[2]	200.8		142.6		576.5		275
U.S. Operating Segment | Screen Advertising, Screen Rental and Promotional Revenues
Disaggregation of Revenue [Line Items]
Total revenue	[1]	20.6	[2]	18	[2]	60.7	[2]	44.5
U.S. Operating Segment | Other Revenues
Disaggregation of Revenue [Line Items]
Total revenue	[2]	32.7		19.5		88.2		37.9
International
Disaggregation of Revenue [Line Items]
Total revenue		138.7		59.4		370.5		102
International | Admissions Revenues
Disaggregation of Revenue [Line Items]
Total revenue		67		30.2		183.2		50.7
International | Concession Revenues
Disaggregation of Revenue [Line Items]
Total revenue		52.8		21.6		136.1		38.5
International | Screen Advertising, Screen Rental and Promotional Revenues
Disaggregation of Revenue [Line Items]
Total revenue	[1]	11.3		4.8		30.7		7.6
International | Other Revenues
Disaggregation of Revenue [Line Items]
Total revenue		$ 7.6		$ 2.8		$ 20.5		$ 5.2
[1] Amount includes amortization of NCM screen advertising advances. See NCM Screen Advertising Advances and Other Deferred Revenue below U.S. segment revenue excludes intercompany transactions with the international operating segment. See Note 16 for the amount of intercompany eliminations for the periods presented.

Revenue Recognition - Summary_2

Revenue Recognition - Summary of Revenues Disaggregated Based on Timing of Revenue Recognition (Detail) - USD ($) $ in Millions		3 Months Ended				9 Months Ended
		Sep. 30, 2022		Sep. 30, 2021		Sep. 30, 2022		Sep. 30, 2021
Disaggregation of Revenue [Line Items]
Total revenue		$ 650.4		$ 434.8		$ 1,855		$ 843.8
U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenue	[1]	511.7		375.4		1,484.5		741.8
International
Disaggregation of Revenue [Line Items]
Total revenue		138.7		59.4		370.5		102
Goods and Services Transferred at a Point in Time
Disaggregation of Revenue [Line Items]
Total revenue		602.7		401.7		1,733.2		769.9
Goods and Services Transferred at a Point in Time | U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenue		478.9	[2]	348.4	[2]	1,401		678.4	[2]
Goods and Services Transferred at a Point in Time | International
Disaggregation of Revenue [Line Items]
Total revenue		123.8		53.3		332.2		91.5
Goods and Services Transferred Over Time
Disaggregation of Revenue [Line Items]
Total revenue	[3]	47.7		33.1		121.8		73.9
Goods and Services Transferred Over Time | U.S. Operating Segment
Disaggregation of Revenue [Line Items]
Total revenue	[2]	32.8	[3]	27	[3]	83.5	[1]	63.4	[3]
Goods and Services Transferred Over Time | International
Disaggregation of Revenue [Line Items]
Total revenue		$ 14.9	[3]	$ 6.1	[3]	$ 38.3		$ 10.5	[3]
[1] U.S. segment revenue excludes intercompany transactions with the international operating segment. See Note 16 for the amount of intercompany eliminations for the periods presented. U.S. segment revenue excludes intercompany transactions with the international operating segment. See Note 16 for the amount of intercompany eliminations for the periods presented. Amount includes amortization of NCM screen advertising advances. See NCM Screen Advertising Advances and Other Deferred Revenue below.

Revenue Recognition - Changes i

Revenue Recognition - Changes in Advances and Deferred Revenues (Detail) - USD ($) $ in Millions		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021
Change in Contract with Customer Liability [Line Items]
Amounts recognized as accounts receivable		$ 5.1
NCM
Change in Contract with Customer Liability [Line Items]
Interest accrued on NCM screen advertising advances		17.5	$ 17.7
N C M Screen Advertising Advances
Change in Contract with Customer Liability [Line Items]
Balance at January 1, 2022	[1]	346
Amounts recognized as accounts receivable	[1]	0
Cash received from customers in advance	[1]	0
Common units received from NCM		1.3
Interest accrued on NCM screen advertising advances		17.5
Revenue recognized during period		(24.3)
Foreign currency translation adjustments	[1]	0
Balance at June 30, 2022	[1]	340.5
Other Deferred Revenues
Change in Contract with Customer Liability [Line Items]
Balance at January 1, 2022	[2]	160.3
Amounts recognized as accounts receivable	[2]	1
Cash received from customers in advance	[2]	163.5
Common units received from NCM	[2]	0
Interest accrued on NCM screen advertising advances	[2]	0
Revenue recognized during period	[2]	(150.9)
Foreign currency translation adjustments	[2]	(1)
Balance at June 30, 2022	[2]	$ 172.9
[1] See Note 8 for the maturity of NCM screen advertising advances as of September 30, 2022 . Includes liabilities associated with outstanding gift cards and discount ticket vouchers, points or rebates outstanding under the Company’s loyalty and membership programs and revenue collected but not yet earned for screen advertising, screen rental and other promotional activities. Amounts are classified as accounts payable and accrued expenses or other long-term liabilities on the condensed consolidated balance sheet.

Revenue Recognition - Aggregate

Revenue Recognition - Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized (Details) - Other Deferred Revenues $ in Millions	Sep. 30, 2022 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation	$ 172.9
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligation	$ 153.3
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligation	$ 19.6
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period
Remaining performance obligation

Revenue Recognition - Aggrega_2

Revenue Recognition - Aggregate Amount of Transaction Price Allocated To Performance Obligation That Are Unsatisfied And Expected To Be Recognized (Details1) $ in Millions	Sep. 30, 2022 USD ($)
Other Deferred Revenues
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation	$ 172.9

Computations of Basic and Dilut

Computations of Basic and Diluted Loss Per Share (Detail) - USD ($) $ / shares in Units, $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Earnings Per Share Disclosure [Line Items]
Net loss attributable to Cinemark Holdings, Inc.		$ (24.5)	$ (77.8)	$ (171.9)	$ (428.5)
Loss allocated to participating share-based awards (1)	[1]	0.4	1.5	2.4	7.6
Net loss attributable to common stockholders		$ (24.1)	$ (76.3)	$ (169.5)	$ (420.9)
Basic weighted average common stock outstanding		118,400,000	117,300,000	118,100,000	117,200,000
Diluted common equivalent shares		118,400,000	117,300,000	118,100,000	117,200,000
Basic loss per share attributable to common stockholders		$ (0.20)	$ (0.65)	$ (1.43)	$ (3.59)
Diluted loss per share attributable to common stockholders		$ (0.20)	$ (0.65)	$ (1.43)	$ (3.59)
Restricted Stock Units (RSUs)
Earnings Per Share Disclosure [Line Items]
Common equivalent shares for restricted stock units		180,000	100,000	390,000	100,000
[1] For the three months ended September 30, 2022 and 2021, a weighted average of approximately 1.90 shares and 2.34 shares of restricted stock, respectively, were considered participating securities. For the nine months ended September 30, 2022 and 2021, a weighted average of approximately 1.69 shares and 2.11 shares of restricted stock, respectively, were considered participating securities.

Computations of Basic and Dil_2

Computations of Basic and Diluted Loss Per Share (Parenthetical) (Detail) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Earnings Per Share Disclosure [Line Items]
Weighted average shares of participating restricted stock	1,900,000	2,340,000	1,690,000	2,110,000
Restricted Stock Units (RSUs)
Earnings Per Share Disclosure [Line Items]
Common equivalent shares for restricted stock units	180,000	100,000	390,000	100,000

Earnings Per Share - Additional

Earnings Per Share - Additional Information (Detail) $ / shares in Units, $ in Millions	9 Months Ended
	Sep. 30, 2022 USD ($) d $ / shares shares	Dec. 31, 2021 $ / shares
Earnings Per Share Disclosure [Line Items]
Interest rate	4.50%
4.50 % Convertible Senior Notes
Earnings Per Share Disclosure [Line Items]
Interest rate	4.50%
Common stock, strike price	$ 18.65
Debt instrument convertible conversion, percentage	(130.00%)
Debt Instrument, Convertible, Associated Derivative Transactions, Description	The if-converted value of the 4.50% Convertible Senior Notes exceeded the aggregate outstanding principal value of the notes by $54.3 as of September 30, 2022.
Exercise price		$ 14.35
Common shares issued | shares	32,000,000
Convertible senior note, if-converted value in excess of outstanding principal value | $	$ 54.3
Stock option granted | shares	32,000,000
Stock option granted, price per share	$ 14.35
Common stock, convertible, conversion price, increase	$ 22.08
Debt Instrument, Convertible, Threshold Trading Days | d	30
4.50 % Convertible Senior Notes | Minimum
Earnings Per Share Disclosure [Line Items]
Debt Instrument, Convertible, Threshold Trading Days | d	20
4.50 % Convertible Senior Notes | Warrant
Earnings Per Share Disclosure [Line Items]
Stock option granted | shares	32,000,000
Stock option granted, price per share	$ 22.08

Long Term Debt - Additional Inf

Long Term Debt - Additional Information (Detail) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($) Agreement	Sep. 30, 2021 USD ($)
Debt Instrument [Line Items]
Interest rate	4.50%		4.50%
Loss on extinguishment of debt			$ 0	$ 6.5
Interest Rate Swap
Debt Instrument [Line Items]
Number of Interest Rate Swap Agreements Amended | Agreement			3
Amortization of accumulated losses for amended swap agreements	$ 1.1	$ 1.1	$ 3.4	$ 3.4
4.50 % Convertible Senior Notes
Debt Instrument [Line Items]
Interest rate	4.50%		4.50%
Term Loan Credit facility | Senior Secured Credit Facility
Debt Instrument [Line Items]
Aggregate principal amount of add-on to Senior Notes	$ 700		$ 700
Amount outstanding under the term loan	628.2		628.2
Quarterly principal payments due			$ 1.6
Last quarterly payment date			Dec. 31, 2024
Final principal payment	$ 613.4		$ 613.4
Final principal payment due date			Mar. 29, 2025
Average interest rate on outstanding borrowings	4.10%		4.10%
Revolving Credit Line | Senior Secured Credit Facility
Debt Instrument [Line Items]
Aggregate principal amount of add-on to Senior Notes	$ 100		$ 100
Amount outstanding under the revolving credit line	0		0
Available borrowing capacity under the revolving credit line	$ 100		$ 100
Revolving credit line, maturity date			Nov. 28, 2024

Long Term Debt - Components of

Long Term Debt - Components of Long-Term Debt (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Long-term debt, less current portion	$ 2,473.5	$ 2,476.3
CNK [Member]
Debt Instrument [Line Items]
Cinemark USA, Inc. term loan due 2025	628.2	633.1
Other	21.9	30.2
Total carrying value of long-term debt	2,530.1	2,543.3
Less current portion	22	24.3
Less: Debt discounts and debt issuance costs, net of accumulated amortization	34.6	42.7
Long-term debt, less current portion	2,473.5	2,476.3
CNK [Member] | 4.500% convertible senior notes due 2025
Debt Instrument [Line Items]
Senior notes	460	460
CNK [Member] | 8.750% senior secured notes due 2025
Debt Instrument [Line Items]
Senior notes	250	250
CNK [Member] | 5.875% senior notes due 2026
Debt Instrument [Line Items]
Senior notes	405	405
CNK [Member] | 5.250% senior notes due 2028
Debt Instrument [Line Items]
Senior notes	765	765
CUSA [Member]
Debt Instrument [Line Items]
Cinemark USA, Inc. term loan due 2025	628.2	633.1
Other	21.9	30.2
Total carrying value of long-term debt	2,070.1	2,083.3
Less current portion	22	24.3
Less: Debt discounts and debt issuance costs, net of accumulated amortization	24.7	30.3
Long-term debt, less current portion	2,023.4	2,028.7
CUSA [Member] | 8.750% senior secured notes due 2025
Debt Instrument [Line Items]
Senior notes	250	250
CUSA [Member] | 5.875% senior notes due 2026
Debt Instrument [Line Items]
Senior notes	405	405
CUSA [Member] | 5.250% senior notes due 2028
Debt Instrument [Line Items]
Senior notes	$ 765	$ 765

Long Term Debt - Summary of Com

Long Term Debt - Summary of Company's Interest Rate Swap Agreements Designated as Cash Flow Hedges (Detail) - Designated as Hedging Instrument - Cash Flow Hedging	9 Months Ended
	Sep. 30, 2022 USD ($)
Debt Instrument [Line Items]
Estimated Fair Value	$ 20,200,000	[1]
Interest Rate Swap Agreement 1
Debt Instrument [Line Items]
Notional Amount	$ 137,500
Effective Date	Dec. 31, 2018
Pay Rate	2.12%
Receive Rate	1-Month LIBOR
Expiration Date	Dec. 31, 2024
Estimated Fair Value	$ 6,100,000	[1]
Interest Rate Swap Agreement 2
Debt Instrument [Line Items]
Notional Amount	$ 175,000
Effective Date	Dec. 31, 2018
Pay Rate	2.12%
Receive Rate	1-Month LIBOR
Expiration Date	Dec. 31, 2024
Estimated Fair Value	$ 8,000,000	[1]
Interest Rate Swap Agreement 3
Debt Instrument [Line Items]
Notional Amount	$ 137,500
Effective Date	Dec. 31, 2018
Pay Rate	2.19%
Receive Rate	1-Month LIBOR
Expiration Date	Dec. 31, 2024
Estimated Fair Value	$ 6,100,000	[1]
[1] Approximately $ 9.9 of the total is included in prepaid expenses and other and $ 10.3 is included in deferred charges and other assets, net on the condensed consolidated balance sheet as of September 30, 2022 .

Long Term Debt - Summary of C_2

Long Term Debt - Summary of Company's Interest Rate Swap Agreements Designated as Cash Flow Hedges (Parenthetical) (Detail) $ in Millions	Sep. 30, 2022 USD ($)
Accounts Payable and Accrued Expenses
Debt Instrument [Line Items]
Estimated Fair Value	$ 9.9
Other Long-term Liabilities
Debt Instrument [Line Items]
Estimated Fair Value	$ 10.3

Long Term Debt - Schedule of ca

Long Term Debt - Schedule of carrying values and fair values of debt instruments (Details) - USD ($) $ in Millions		Sep. 30, 2022	Dec. 31, 2021
CNK [Member]
Debt Instrument [Line Items]
Fair value	[1]	$ 2,326.2	$ 2,749.8
CUSA [Member]
Debt Instrument [Line Items]
Fair value		$ 1,798.7	$ 2,058
[1] Includes the fair value of the 4.500 % convertible senior notes of $ 527.5 and $ 691.9 as of September 30, 2022 and December 31, 2021, respectively.

Long Term Debt - Schedule of _2

Long Term Debt - Schedule of carrying values and fair values of debt instruments (Parenthical) (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Interest rate	4.50%
Convertible Senior Notes
Debt Instrument [Line Items]
Fair value of long-term debt	$ 527.5	$ 691.9

Summary of Activity with NCM In

Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Detail) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Schedule Of Equity Method Investments [Line Items]
Beginning Balance				$ (346)
Impairment of investment in NCM		$ 15.2	$ 7.5	107.5	$ 7.5
Equity income				(7.5)	$ (22.1)
Impairment of investment in NCM				98
Ending Balance		(340.5)		(340.5)
Investment In NCM
Schedule Of Equity Method Investments [Line Items]
Beginning Balance				135.4
Receipt of common units due to annual common unit adjustment ("CUA")				(1.3)
Equity income				(10.3)
Ending Balance		28.4		28.4
N C M Screen Advertising Advances
Schedule Of Equity Method Investments [Line Items]
Beginning Balance				(346)
Receipt of common units due to annual common unit adjustment ("CUA")				1.3
Interest accrued related to significant financing component				(17.5)
Amortization of screen advertising advances				24.3
Ending Balance		(340.5)		(340.5)
Equity in Loss
Schedule Of Equity Method Investments [Line Items]
Equity income				10.3
Ending Balance		10.3		10.3
Other Revenues
Schedule Of Equity Method Investments [Line Items]
Screen rental revenue earned under ESA	[1]			(15)
Amortization of screen advertising advances				(24.3)
Ending Balance		(39.3)		(39.3)
Interest Expense - NCM
Schedule Of Equity Method Investments [Line Items]
Interest accrued related to significant financing component				17.5
Ending Balance		17.5		17.5
Cash Received
Schedule Of Equity Method Investments [Line Items]
Screen rental revenue earned under ESA	[1],[2]			15
Ending Balance	[2]	$ 15		$ 15
[1] Amounts include the per patron and per digital screen theatre access fees due to CUSA, net of amounts due to NCM for on-screen advertising time provided to the Company's beverage concessionaire of approximately $ 5.9 . The Company had a receivable from NCM of $ 5.1 as of September 30, 2022

Summary of Activity with NCM _2

Summary of Activity with NCM Included in Company's Consolidated Financial Statements (Parenthetical) (Detail) $ in Millions	9 Months Ended
	Sep. 30, 2022 USD ($)
Equity Method Investments and Joint Ventures [Abstract]
Company's beverage concessionaire advertising costs	$ 5.9
Amounts recognized as accounts receivable	$ 5.1

Investment in National CineMe_3

Investment in National CineMedia LLC - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended	9 Months Ended
	Apr. 30, 2022	Sep. 30, 2022	Sep. 30, 2021
Schedule Of Equity Method Investments [Line Items]
Number of additional common units of NCM receive under common unit adjustment agreement		500,000
Estimated fair value of additional common units received	$ 1.3	$ 1.3	$ 10.2
Investment impairment expense		98
NCM
Schedule Of Equity Method Investments [Line Items]
Recognized incremental screen rental revenue and offsetting interest expense		17.5	17.7
Amortization of screen advertising advances		$ 24.3	$ 24
NCM | Minimum
Schedule Of Equity Method Investments [Line Items]
Percentage of incremental borrowing rates		4.40%
NCM | Maximum
Schedule Of Equity Method Investments [Line Items]
Percentage of incremental borrowing rates		8.30%
Investment In NCM
Schedule Of Equity Method Investments [Line Items]
Number of common units of NCM owned by Company		43,700,000
Interest in common units of NCM owned by Company		25.50%
Common unit convertible into share of NCMI common stock, conversion ratio		1
Estimated fair value of investment using NCM's stock price		$ 28.4
NCMI common stock price		$ 0.65

Summary of Recognition of Reven

Summary of Recognition of Revenue Related To Deferred Revenue (Details) - N C M Screen Advertising Advances $ in Millions	Sep. 30, 2022 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation	$ 340.5
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligation	$ 9.6	[1]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligation	$ 10.3	[1]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligation	$ 11	[1]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligation	$ 11.8	[1]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Remaining performance obligation	$ 12.6	[1]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period
Remaining performance obligation	$ 285.2	[1]
[1] Amounts are net of the estimated interest to be accrued for the periods presented. See discussion of significant financing component below.

Summary of Recognition of Rev_2

Summary of Recognition of Revenue Related To Deferred Revenue (Details1) $ in Millions	Sep. 30, 2022 USD ($)
N C M [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation	$ 340.5

Summary Financial Information f

Summary Financial Information for National CineMedia (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 30, 2021
Schedule Of Equity Method Investments [Line Items]
Net loss attributable to Cinemark Holdings, Inc.	$ (24.5)	$ (77.8)	$ (171.9)	$ (428.5)
Noncurrent assets	32.6		32.6		$ 22.3
Current liabilities	628.4		628.4		769.1
Noncurrent liabilities	4,016.7		4,016.7		$ 4,127
Ncm [Member]
Schedule Of Equity Method Investments [Line Items]
Gross revenue	54.5	31.7	157.5	51.1
Operating income (loss)	(4.3)	(18.7)	(21.2)	(76.6)
Net loss attributable to Cinemark Holdings, Inc.	(24.4)	$ (35.3)	(79)	$ (125.7)
Current assets	123.5		123.5			$ 115.4
Noncurrent assets	637.5		637.5			658
Current liabilities	72.7		72.7			67.2
Noncurrent liabilities	1,162.4		1,162.4			1,114.7
Members deficit	$ (474.1)		$ (474.1)			$ (408.5)

Other Investments - Additional

Other Investments - Additional Information (Detail) - Digital Cinema Implementation Partners $ in Millions	9 Months Ended
	Sep. 30, 2022 USD ($) Studio	Dec. 31, 2021 USD ($)
Schedule Of Equity Method Investments [Line Items]
Percentage of voting interest	33%
Economic interest in Digital Cinema Implementation Partners	24.30%
Investment | $	$ 0	$ 0
Number of major motion picture studio, long-term digital cinema deployment agreements | Studio	6

Other Investments- Summary Fina

Other Investments- Summary Financial Information for DCIP (Detail) - USD ($) $ in Millions	3 Months Ended						9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020
Schedule Of Equity Method Investments [Line Items]
Total revenue	$ 650.4			$ 434.8			$ 1,855	$ 843.8
Net income (loss)	(23.9)	$ (72.8)	$ (72.5)	(77.6)	$ (142.2)	$ (208.9)	(169.2)	(428.7)
Current assets	800.9						800.9		$ 874.4
Current liabilities	628.4						628.4		769.1
Noncurrent liabilities	4,016.7						4,016.7		4,127
Members' equity	$ 205.4	$ 218.7	$ 299.4	$ 314.8	$ 397.7	$ 523.8	$ 205.4	$ 314.8	$ 334.5	$ 798.9

Other Investments - Schedule of

Other Investments - Schedule of distributions and warranty reimbursements from DCIP (Details) - DCIP [Member] - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Warranty reimbursements	[1]	$ 0	$ (0.1)	$ 0	$ (0.8)
Distributions from DCIP	[2]	$ 3.7	$ 6.5	$ 3.7	$ 6.5
[1] Recorded as a reduction of utilities and other costs on the condensed consolidated statements of loss. Cash distributions received from DCIP are not treated as a reduction of the investment balance because, as discussed above, the Company's equity investment in DCIP is zero. Reflected as distributions from DCIP on the condensed consolidated statements of loss.

Other Investments- Summary of A

Other Investments- Summary of Activity for Each of Company's Other Investments (Detail) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance	$ 25.2
Cash distributions received	(1.5)	$ (0.2)
Equity income	(7.5)	$ (22.1)
Investments, ending balance	26.3
AC JV, LLC
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance	3.7
Cash distributions received	(1.5)
Equity income	1.6
Other	0
Investments, ending balance	3.8
Digital Cinema Distribution Coalition
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance	25.2
Cash distributions received	(1.5)
Equity income	2.8
Other	(0.2)
Investments, ending balance	26.3
Other Affiliates | Digital Cinema Distribution Coalition
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance	1.8
Cash distributions received	0
Equity income	0.1
Other	0
Investments, ending balance	1.9
Other Affiliates | FE Concepts, LLC
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance	19.3
Cash distributions received	0
Equity income	1.1
Other	0
Investments, ending balance	20.4
Other Affiliates | Other Investments
Schedule Of Equity Method Investments [Line Items]
Investments, beginning balance	0.4
Cash distributions received	0
Equity income	0
Other	(0.2)
Investments, ending balance	$ 0.2

Other Investments- Summary of T

Other Investments- Summary of Transactions with Each of the Company's Other Investees (Detail) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Schedule Of Equity Method Investments [Line Items]
Total revenue		$ 650.4	$ 434.8	$ 1,855	$ 843.8
AC JV, LLC | Film rentals and advertising
Schedule Of Equity Method Investments [Line Items]
Event fees paid	[1]	2.1	0.8	6.6	1.4
Digital Cinema Distribution Coalition
Schedule Of Equity Method Investments [Line Items]
Content delivery fees paid	[1]	$ 0.1	$ 0.2	$ 0.4	$ 0.4
[1] Included in film rentals and advertising costs on the condensed consolidated statements of loss.

Summary of Treasury Stock Activ

Summary of Treasury Stock Activity (Detail) $ in Millions	9 Months Ended
	Sep. 30, 2022 USD ($) shares
Treasury Stock, Shares [Abstract]
Beginning Balance, Shares | shares	5,350,000
Restricted stock withholdings | shares	240,000	[1]
Restricted stock forfeitures | shares	70,000
Ending Balance, Shares | shares	5,660,000
Beginning Balance, Cost | $	$ 91.1
Restricted stock withholdings | $	4.1	[1]
Restricted stock forfeitures | $	0
Ending Balance, Cost | $	$ 95.2
[1] Holdings withheld shares as a result of the election by certain employees to satisfy their tax liabilities upon vesting of restricted stock and restricted stock units. Holdings determined the number of shares to be withheld based upon market values of the common stock of Holdings on the vest dates, which ranged from $ 15.18 to $ 18.33 per share.

Summary of Treasury Stock Act_2

Summary of Treasury Stock Activity (Parenthetical) (Detail)	9 Months Ended
	Sep. 30, 2022 $ / shares
Minimum
Schedule of Treasury Stock [Line Items]
Market Value of Restricted Shares	$ 15.18
Maximum
Schedule of Treasury Stock [Line Items]
Market Value of Restricted Shares	$ 18.33

Treasury Stock and Share Base_3

Treasury Stock and Share Based Awards - Additional Information (Detail) $ / shares in Units, $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2022 USD ($) shares	Sep. 30, 2022 USD ($) $ / shares shares
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant		$ 16.40
Restricted Stock
Stockholders Equity Note [Line Items]
Number of restricted shares granted | shares		880,000
Restricted Stock | Minimum
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant		$ 13.36
Forfeiture rate for restricted stock awards		0%
Award vesting period for restricted stock		1 year
Restricted Stock | Maximum
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant		$ 17.07
Forfeiture rate for restricted stock awards		12%
Award vesting period for restricted stock		3 years
Restricted Stock Units (RSUs)
Stockholders Equity Note [Line Items]
Market value of common stock on the dates of grant		$ 16.65
Forfeiture rate for restricted stock awards		5%
Unrecognized compensation expense | $	$ 12	$ 12
Remaining compensation expense recognition period (in years)		2 years
incremental compensation expense | $	$ 0.6	$ 0.6
Share-based compensation arrangement by share-based payment award, description		The performance measurement period for these performance awards is one year with an additional service requirement to the third anniversary of the date of grant. Each performance target underlying the performance award has a threshold, target and maximum level, with the maximum level equal to 175% of the target award. If the performance metrics meet the threshold level, approximately 29% of the maximum restricted stock units vest. If the performance metrics for the one-year period are at target, approximately 57% of the maximum restricted stock units vest. If the performance metrics are at the maximum, 100% of the maximum restricted stock units vest. Grantees are eligible to receive a ratable portion of the common stock issuable if the achievement of the performance goals is within the targets previously noted.
Share-based compensation arrangement by share-based payment award, vesting condition		All restricted stock units granted during 2022 will be paid in the form of Holdings' common stock if the participant continues to provide services through the third anniversary of the grant date. Restricted stock unit award participants are eligible to receive dividend equivalent payments from the grant date to the extent declared by Holdings if, and at the time that, the restricted stock unit awards vest.
Number of hypothetical shares of common stock at IRR levels | shares	1,000,000	1,000,000
Number of hypothetical shares of common stock | shares		800,000

Summary of Restricted Stock Act

Summary of Restricted Stock Activity (Detail)	9 Months Ended
	Sep. 30, 2022 $ / shares shares
Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value Outstanding, Beginning | $ / shares	$ 21.73
Weighted Average Grant Date Fair Value, Granted | $ / shares	16.40
Weighted Average Grant Date Fair Value, Vested | $ / shares	19
Weighted Average Grant Date Fair Value, Forfeited | $ / shares	18.80
Weighted Average Grant Date Fair Value Outstanding, Ending | $ / shares	20.66
Weighted Average Grant Date Fair Value, Unvested restricted stock | $ / shares	$ 20.66
Restricted Stock
Shares of Restricted Stock
Shares of Restricted Stock, Beginning balance | shares	2,000,000
Shares of Restricted Stock, Granted | shares	880,000
Shares of Restricted Stock, Vested | shares	(900,000)
Shares of Restricted Stock, Forfeited | shares	(70,000)
Shares of Restricted Stock, Ending balance | shares	1,910,000
Shares of Restricted Stock, Unvested restricted stock | shares	1,910,000

Summary of Restricted Stock and

Summary of Restricted Stock and Restricted Stock Unit Award Activity (Detail) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of restricted stock units that vested during the period	900,000
Fair value of restricted stock units that vested during the period	$ 15.2	$ 2.5
Compensation expense recognized during the period	12	13.8
Income tax benefit (cost) related to restricted stock units	$ 2.5	$ (0.1)
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of restricted stock units that vested during the period	100,000	10,000
Fair value of restricted stock units that vested during the period	$ 1.7	$ 0.3
Accumulated dividends paid upon vesting of restricted stock units	0.3	0.1
Compensation expense recognized during the period	4.2	2.8
Income tax benefit (cost) related to restricted stock units	0.1	(0.5)
Estimated remaining expense	23.8
Cinemark Holdings Inc [Member] | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of restricted stock units that vested during the period	0.6	1.3
Compensation expense recognized during the period	0.7	0.7
Income tax benefit (cost) related to restricted stock units	0.1	0.3
Cinemark Holdings Inc [Member] | Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Estimated remaining expense	0.8
Cinemark Partners Second [Member] | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of restricted stock units that vested during the period	14.6	1.2
Compensation expense recognized during the period	11.3	13.1
Income tax benefit (cost) related to restricted stock units	2.4	$ (0.4)
Cinemark Partners Second [Member] | Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Estimated remaining expense	$ 23

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets - Net Summary of Goodwill (Detail) $ in Millions	9 Months Ended
	Sep. 30, 2022 USD ($)
Goodwill [Line Items]
Beginning Balance	$ 1,248.8	[1]
Foreign currency translation adjustments	0.4
Ending Balance	1,249.2	[1]
Us Operating Segment [Member]
Goodwill [Line Items]
Beginning Balance	1,182.9	[1]
Foreign currency translation adjustments	0
Ending Balance	1,182.9	[1]
International Operating Segment [Member]
Goodwill [Line Items]
Beginning Balance	65.9	[1]
Foreign currency translation adjustments	0.4
Ending Balance	$ 66.3	[1]
[1] Balances are presented net of accumulated impairment losses of $ 214.0 for the U.S. operating segment and $ 43.8 for the international operating segment. See discussion of the qualitative impairment analysis performed by the Company as of September 30, 2022 at Note 12.

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets - Net Summary of Goodwill (Parenthetical) (Detail) $ in Millions	Sep. 30, 2022 USD ($)
Us Operating Segment [Member]
Goodwill [Line Items]
Accumulated impairment losses	$ 214
International Operating Segment [Member]
Goodwill [Line Items]
Accumulated impairment losses	$ 43.8

Goodwill and Other Intangible_5

Goodwill and Other Intangible Assets - Net Intangible Assets (Detail) $ in Millions	9 Months Ended
	Sep. 30, 2022 USD ($)
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Intangible assets with finite lives, Beginning balance	$ 81.8
Foreign Currency Translation Adjustments, Gross carrying amount	0.1
Other finite lived intangible assets gross	0.2	[1]
Intangible assets with finite lives, Ending balance	81.7
Intangible assets with finite lives, Accumulated amortization, Beginning balance	(71.1)
Accumulated amortization	(1.8)
Other finite lived intangible accumulated amortization	0.2	[1]
Intangible assets with finite lives, Accumulated amortization, Ending balance	(72.7)
Net intangible assets with finite lives, Beginning balance	10.7
Amortization, intangible assets	(1.8)
Foreign Currency Translation Adjustments, Finite lived intangible assets	0.1
Net intangible assets with finite lives, Ending balance	9
Indefinite-lived Intangible Assets, Tradename and Other, Beginning Balance	300.1
Indefinite-lived Intangible Assets, Tradename and Other, Ending Balance	300.1
Total intangible assets - net, Beginning balance	310.8
Amortization, Total intangible assets net	(1.8)
Foreign Currency Translation Adjustments, Total intangible assets - net	0.1
Total intangible assets - net, Ending balance	$ 309.1
[1] Amounts represent the write-off of non-compete agreements that expired during the nine months ended September 30, 2022 .

Goodwill and Other Intangible_6

Goodwill and Other Intangible Assets - Net Estimated Aggregate Future Amortization Expense for Intangible Assets (Detail) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets, Net [Abstract]
For the nine months ended December 31, 2022	$ 0.6
For the twelve months ended December 31, 2023	2.5
For the twelve months ended December 31, 2024	2.5
For the twelve months ended December 31, 2025	1.9
For the twelve months ended December 31, 2026	1.5
Thereafter	0
Total	$ 9	$ 10.7

Summary of Impairment Charges (

Summary of Impairment Charges (Detail) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Impaired Long-Lived Assets Held and Used [Line Items]
Total Impairment		$ 15.2	$ 7.5	$ 107.5	$ 7.5
U.S. Operating Segment
Impaired Long-Lived Assets Held and Used [Line Items]
Theatre properties		1.1	4.8	3.6	4.8
Theatre operating lease right-of-use assets		2.7	2.6	4.7	2.6
Investment in NCM	[1]	11.2	0	98	0
Total Impairment		15	7.4	106.3	7.4
International
Impaired Long-Lived Assets Held and Used [Line Items]
Theatre properties		0.1	0.1	0.8	0.1
Theatre operating lease right-of-use assets		0.1	0	0.4	0
International total		$ 0.2	$ 0.1	$ 1.2	$ 0.1
[1] See discussion at Impairment of NCM Investment in Note 8.

Summary of Assets and Liabiliti

Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail) - Fair Value Measurements, Recurring - USD ($) $ in Millions		Sep. 30, 2022	Dec. 31, 2021
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Interest rate swap liabilities	[1]		$ 14.6
Interest rate swap assets	[1]	$ 20.2
Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Interest rate swap liabilities	[1]		$ 14.6
Interest rate swap assets	[1]	$ 20.2
[1] See further discussion of interest rate swaps at Note 7.

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2022 USD ($)
Fair Value Disclosures [Abstract]
Fair value, asset transfers out of Level 3	$ 0
Fair value, asset transfers into Level 3	0
Fair Value of Assets Transfers in or Out Level 1 to Level 2	0
Fair value of assets transfers in or out, level 2 to level 1	$ 0

Foreign Currency Translation -

Foreign Currency Translation - Additional Information (Detail) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Financial Statement Line Items with Differences in Reported Amount and Reporting Currency Denominated Amounts [Line Items]
Accumulated other comprehensive income (loss)	$ 362.9	$ 394.5
Cumulative foreign currency losses	$ 400.4	394.5
Cumulative inflation rate	100%
Cumulative inflation period	3 years
CNK [Member]
Financial Statement Line Items with Differences in Reported Amount and Reporting Currency Denominated Amounts [Line Items]
Accumulated other comprehensive income (loss)	$ 362.9	394.5
CUSA [Member]
Financial Statement Line Items with Differences in Reported Amount and Reporting Currency Denominated Amounts [Line Items]
Accumulated other comprehensive income (loss)	$ 368.2	$ 397

Summary of Impact of Translatin

Summary of Impact of Translating Financial Statements of Company's International Subsidiaries (Detail) $ in Millions	9 Months Ended
	Sep. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Dec. 31, 2021
Foreign Currency Translation [Line Items]
Other comprehensive Loss	$ (5.9)	$ (15)
Brazil
Foreign Currency Translation [Line Items]
Exchange Rate	5.40		5.57
Other comprehensive Loss	$ 0.4	(3.4)
Chile
Foreign Currency Translation [Line Items]
Exchange Rate	965.80		852
Other comprehensive Loss	$ (7.7)	(7.9)
Peru
Foreign Currency Translation [Line Items]
Exchange Rate	3.99		4.02
Other comprehensive Loss	$ 0.2	(3.6)
Other foreign countries
Foreign Currency Translation [Line Items]
Other comprehensive Loss	$ 1.2	$ (0.1)

Summary of Impact of Translat_2

Summary of Impact of Translating Financial Statements of Company's International Subsidiaries (Parenthetical) (Detail) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Argentina
Foreign Currency Translation [Line Items]
Foreign currency exchange loss	$ 5.1	$ 0.4

Supplemental Information to Con

Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail) - USD ($) $ in Millions		1 Months Ended	9 Months Ended
		Apr. 30, 2022	Sep. 30, 2022	Sep. 30, 2021
Schedule Of Cash Flow Supplemental [Line Items]
Cash paid (refunds received) for income taxes, net			$ 2.3	$ (136.9)
Increase (Decrease) in Restricted Investments for Operating Activities	[1]		(2.9)	7.3
Noncash investing and financing activities:
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment	[2]		4.2	(2.4)
Investment in NCM – receipt of common units (see Note 9)		$ 1.3	1.3	10.2
NCM
Noncash investing and financing activities:
Interest expense - NCM			(17.5)	(17.7)
Cinemark Partners Second [Member]
Schedule Of Cash Flow Supplemental [Line Items]
Cash paid for interest			100.3	69.5
Cinemark Holdings Inc [Member]
Schedule Of Cash Flow Supplemental [Line Items]
Cash paid for interest	[3]		$ 121	$ 89.8
[1] Represents cash deposited in a collateral account during the period to support the issuance of letters of credit to lenders, net of deposits withdrawn from such accounts upon the repayment of related debt. Additions to theatre properties and equipment included in accounts payable as of September 30, 2022 and December 31, 2021 were $ 12.4 and $ 8.2 , respectively. Includes the cash interest paid by CUSA.

Supplemental Information to C_2

Supplemental Information to Condensed Consolidated Statements of Cash Flows (Parenthetical) (Detail) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Supplemental Cash Flow Elements [Abstract]
Additions to theatre properties and equipment included in accounts payable	$ 12.4	$ 8.2

Selected Financial Information

Selected Financial Information by Reportable Operating Segment (Detail) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Segment Reporting Information [Line Items]
Revenues		$ 650.4	$ 434.8	$ 1,855	$ 843.8
Capital expenditures				65.3	57.2
U.S. Operating Segment
Segment Reporting Information [Line Items]
Revenues	[1]	511.7	375.4	1,484.5	741.8
International
Segment Reporting Information [Line Items]
Revenues		138.7	59.4	370.5	102
Operating Segments
Segment Reporting Information [Line Items]
Revenues		650.4	434.8	1,855	843.8
Adjusted EBITDA		99.5	44.3	263	(59.5)
Capital expenditures		24.7	24.4	65.3	57.2
Operating Segments | U.S. Operating Segment
Segment Reporting Information [Line Items]
Revenues		514.4	376.3	1,491.6	743
Adjusted EBITDA		70.7	44.8	196.2	(31.7)
Capital expenditures		20.2	22.4	50.7	47.5
Operating Segments | International
Segment Reporting Information [Line Items]
Revenues		138.7	59.3	370.5	101.9
Adjusted EBITDA		28.8	(0.5)	66.8	(27.8)
Capital expenditures		4.5	2	14.6	9.7
Eliminations
Segment Reporting Information [Line Items]
Revenues		$ (2.7)	$ (0.8)	$ (7.1)	$ (1.1)
[1] U.S. segment revenue excludes intercompany transactions with the international operating segment. See Note 16 for the amount of intercompany eliminations for the periods presented.

Reconciliation of Net Income (L

Reconciliation of Net Income (Loss) to Adjusted EBITDA (Detail) - USD ($) $ in Millions		3 Months Ended						9 Months Ended
		Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021
Segment Reporting Information [Line Items]
Net loss		$ (23.9)	$ (72.8)	$ (72.5)	$ (77.6)	$ (142.2)	$ (208.9)	$ (169.2)	$ (428.7)
Add (deduct):
Cash distributions and other cash distributions from equity investees								1.5	0.2
Impairment of investment in NCM		15.2			7.5			107.5	7.5
Loss on extinguishment of debt								0	6.5
Non-cash rent expense								(7.5)	(1.8)
Share based awards compensation expense								16.2	16.6
Digital Cinema Implementation Partners
Segment Reporting Information [Line Items]
Net loss		(23.9)			(77.6)			(169.2)	(428.7)
Add (deduct):
Income taxes		3.4			(8.9)			6.3	(15.6)
Interest expense	[1]	38.4			38			114.6	111.6
Other expense, net	[2]	4.5			12.5			19.2	35.3
Depreciation and amortization		58.3			67.2			181	202.3
Impairment of investment in NCM		15.2			7.5			107.5	7.5
Restructuring costs		0			(0.4)			(0.2)	(1.3)
(Gain) loss on disposal of assets and other		1.2			1.1			(6.4)	7.9
Loss on extinguishment of debt		0			0			0	6.5
Non-cash rent expense		(2.8)			(1.1)			(7.5)	(1.8)
Share based awards compensation expense		5.2			6			16.2	16.6
Adjusted EBITDA		99.5			44.3			263	(59.5)
Digital Cinema Implementation [Member]
Add (deduct):
Cash distributions and other cash distributions from equity investees	[3]	$ 0			$ 0			$ 1.5	$ 0.2
[1] Includes amortization of debt issuance costs and amortization of accumulated losses for amended swap agreements. Includes interest income, foreign currency exchange (gain) loss and equity in loss of affiliates. Reflects cash distributions received from equity investees that were recorded as a reduction of the respective investment balances (see Note 9). These distributions are reported entirely within the U.S. operating segment.

Selected Financial Informatio_2

Selected Financial Information by Geographic Area (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ 650.4	$ 434.8	$ 1,855	$ 843.8
Theatre properties and equipment, net	1,260		1,260		$ 1,382.9
Reportable Geographical Components
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	650.4	434.8	1,855	843.8
Theatre properties and equipment, net	1,260		1,260		1,382.9
Reportable Geographical Components | U.S.
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	514.4	376.3	1,491.6	743
Theatre properties and equipment, net	1,105.4		1,105.4		1,208.7
Reportable Geographical Components | Brazil
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	45.2	20.6	133.1	30.5
Theatre properties and equipment, net	49.6		49.6		56.8
Reportable Geographical Components | Other international countries
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	93.5	38.6	237.4	71.4
Theatre properties and equipment, net	105		105		$ 117.4
Reportable Geographical Components | Eliminations
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ (2.7)	$ (0.7)	$ (7.1)	$ (1.1)

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail) $ in Millions	9 Months Ended		12 Months Ended
	Sep. 30, 2022 USD ($) Theatre	Sep. 30, 2021 USD ($)	Dec. 31, 2021 USD ($)
Related Party Transaction [Line Items]
Management fee	$ 0.1	$ 0.1
Consulting Services Paid	0.2
Net receivable from Holdings	$ 60.5		$ 46.7
FE Concepts, LLC
Related Party Transaction [Line Items]
Percentage of voting interest	50%
Laredo Theatre, Ltd
Related Party Transaction [Line Items]
Company's interest in Laredo	75%
Lone Star Theatre's interest in Laredo	25%
Ownership interest held by David Roberts	100%
Percentage of common stock held by Chairman of the Board of Directors	8.50%
Percentage of management fees based on theatre revenues	5%
Management fee revenues	$ 0.5	0.2
Excess cash distribution paid	$ 2.4
Syufy Enterprises, LP
Related Party Transaction [Line Items]
Number of theatres leased | Theatre	13
Total rent paid to Syufy	$ 16.7	17.9
Cinemark Partners Second [Member]
Related Party Transaction [Line Items]
Contributions from parent		$ 120